SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
----------------------------------------------------
FORM 10-Q
(mark one)
[ X ] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the Quarter Ended July 3, 1999
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Commission File Number 1-8002
THERMO ELECTRON CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 04-2209186
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
81 Wyman Street, P.O. Box 9046
Waltham, Massachusetts 02454-9046
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (781) 622-1000
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [ X ] No [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
Common Stock, as of the latest practicable date.
Class Outstanding at July 30, 1999
Common Stock, $1.00 par value 158,184,285
<PAGE>
<TABLE>
<CAPTION>
PART I - FINANCIAL INFORMATION
Item 1 - Financial Statements
THERMO ELECTRON CORPORATION
Consolidated Balance Sheet
(Unaudited)
<S> <C> <C>
Assets
July 3, January 2,
(In thousands) 1999 1999
- ---------------------------------------------------------------------------------- ------------ ----------
Current Assets:
Cash and cash equivalents $ 386,864 $ 396,670
Short-term available-for-sale investments at quoted market value 681,197 1,150,585
(amortized cost of $677,486 and $1,144,785)
Accounts receivable, less allowances of $63,272 and $52,607 930,228 875,615
Unbilled contract costs and fees 82,512 87,031
Inventories:
Raw materials and supplies 275,327 267,901
Work in process 142,341 127,144
Finished goods 228,324 204,662
Prepaid income taxes 156,878 143,352
Prepaid expenses 58,093 48,369
---------- ----------
2,941,764 3,301,329
---------- ----------
Property, Plant, and Equipment, at Cost 1,153,583 1,291,485
Less: Accumulated depreciation and amortization 442,735 458,523
---------- ----------
710,848 832,962
---------- ----------
Long-term Available-for-sale Investments, at Quoted Market Value 97,432 95,537
(amortized cost of $93,834 and $99,256)
---------- ----------
Other Assets 259,510 186,168
---------- ----------
Cost in Excess of Net Assets of Acquired Companies (Note 6) 1,925,437 1,915,649
---------- ----------
$5,934,991 $6,331,645
========== ==========
2
<PAGE>
THERMO ELECTRON CORPORATION
Consolidated Balance Sheet (continued)
(Unaudited)
Liabilities and Shareholders' Investment
July 3, January 2,
(In thousands except share amounts) 1999 1999
- ---------------------------------------------------------------------------------- ------------ ----------
Current Liabilities:
Notes payable and current maturities of long-term obligations $ 171,922 $ 134,071
Accounts payable 282,057 272,503
Accrued payroll and employee benefits 147,248 142,323
Accrued income taxes 23,926 92,623
Accrued installation and warranty costs 74,198 71,118
Deferred revenue 65,824 60,582
Other accrued expenses (Notes 6 and 7) 474,368 365,103
---------- ----------
1,239,543 1,138,323
---------- ----------
Deferred Income Taxes and Other Deferred Items 145,164 175,984
---------- ----------
Long-term Obligations:
Senior convertible obligations 187,042 187,042
Senior notes 150,000 150,000
Subordinated convertible obligations 1,588,071 1,639,052
Nonrecourse tax-exempt obligations 14,500 15,500
Other 44,147 33,937
---------- ----------
1,983,760 2,025,531
---------- ----------
Minority Interest 555,518 649,382
---------- ----------
Common Stock of Subsidiaries Subject to Redemption ($59,003 and 57,871 94,301
$95,262 redemption value)
---------- ----------
Shareholders' Investment:
Preferred stock, $100 par value, 50,000 shares authorized; none issued
Common stock, $1 par value, 350,000,000 shares authorized; 167,253 166,971
167,253,232 and 166,970,806 shares issued
Capital in excess of par value 1,027,956 1,033,799
Retained earnings 1,009,652 1,216,541
Treasury stock at cost, 9,100,980 and 8,477,707 shares (161,598) (151,643)
Deferred compensation (6,524) -
Accumulated other comprehensive items (Note 2) (83,604) (17,544)
---------- ----------
1,953,135 2,248,124
---------- ----------
$5,934,991 $6,331,645
========== ==========
The accompanying notes are an integral part of these consolidated financial
statements.
3
<PAGE>
THERMO ELECTRON CORPORATION
Consolidated Statement of Operations
(Unaudited)
Three Months Ended
July 3, July 4,
(In thousands except per share amounts) 1999 1998
- ---------------------------------------------------------------------------------- ----------- -----------
Revenues:
Product and service revenues $1,044,048 $ 899,968
Research and development contract revenues 48,292 47,831
---------- -----------
1,092,340 947,799
---------- -----------
Costs and Operating Expenses:
Cost of product and service revenues (Note 7) 642,488 520,351
Expenses for research and development (a) 111,348 93,652
Selling, general, and administrative expenses (Note 7) 283,301 224,200
Restructuring and other nonrecurring costs, net (Note 7) 391,258 4,112
---------- -----------
1,428,395 842,315
---------- -----------
Operating Income (Loss) (336,055) 105,484
Gain on Issuance of Stock by Subsidiaries - 14,601
Other Income (Expense), Net (Notes 3 and 7) (34,283) 7,327
---------- -----------
Income (Loss) Before Income Taxes, Minority Interest, and Extraordinary Item (370,338) 127,412
Income Tax (Provision) Benefit (Note 7) 87,632 (51,093)
Minority Interest (Expense) Income 47,518 (16,697)
---------- -----------
Income (Loss) Before Extraordinary Item (235,188) 59,622
Extraordinary Item, Net of Provision for Income Taxes and Minority - 2,163
Interest of $3,582 (Note 4)
---------- -----------
Net Income (Loss) $ (235,188) $ 61,785
========== ===========
Earnings (Loss) per Share (Note 4):
Basic $ (1.49) $ .37
========== ===========
Diluted $ (1.49) $ .34
========== ===========
Weighted Average Shares (Note 4):
Basic 158,010 166,168
========== ===========
Diluted 158,010 183,329
========== ===========
(a) Includes Costs of:
Research and development contracts $ 43,100 $ 40,634
Internally funded research and development 68,248 53,018
---------- -----------
$ 111,348 $ 93,652
========== ===========
The accompanying notes are an integral part of these consolidated financial
statements.
4
<PAGE>
THERMO ELECTRON CORPORATION
Consolidated Statement of Operations
(Unaudited)
Six Months Ended
July 3, July 4,
(In thousands except per share amounts) 1999 1998
- ---------------------------------------------------------------------------------- ----------- -----------
Revenues:
Product and service revenues $2,006,466 $ 1,800,965
Research and development contract revenues 95,412 91,097
---------- -----------
2,101,878 1,892,062
---------- -----------
Costs and Operating Expenses:
Cost of product and service revenues (Note 7) 1,224,548 1,054,045
Expenses for research and development (a) 213,273 184,970
Selling, general, and administrative expenses (Note 7) 541,103 451,054
Restructuring and other nonrecurring costs (Note 7) 388,291 4,112
---------- -----------
2,367,215 1,694,181
---------- -----------
Operating Income (Loss) (265,337) 197,881
Gain on Issuance of Stock by Subsidiaries - 54,206
Other Income (Expense), Net (Notes 3 and 7) (41,683) 4,958
---------- -----------
Income (Loss) Before Income Taxes, Minority Interest, and Extraordinary Item (307,020) 257,045
Income Tax (Provision) Benefit (Note 7) 56,733 (91,887)
Minority Interest (Expense) Income 43,398 (40,766)
---------- -----------
Income (Loss) Before Extraordinary Item (206,889) 124,392
Extraordinary Item, Net of Provision for Income Taxes and Minority - 2,886
Interest of $4,844 (Note 4)
---------- -----------
Net Income (Loss) $ (206,889) $ 127,278
========== ===========
Earnings (Loss) per Share (Note 4):
Basic $ (1.31) $ .78
========== ===========
Diluted $ (1.32) $ .71
========== ===========
Weighted Average Shares (Note 4):
Basic 158,028 162,650
========== ===========
Diluted 158,028 179,955
========== ===========
(a) Includes Costs of:
Research and development contracts $ 84,376 $ 79,361
Internally funded research and development 128,897 105,609
---------- -----------
$ 213,273 $ 184,970
========== ===========
The accompanying notes are an integral part of these consolidated financial
statements.
5
<PAGE>
THERMO ELECTRON CORPORATION
Consolidated Statement of Cash Flows
(Unaudited)
Six Months Ended
July 3, July 4,
(In thousands) 1999 1998
- --------------------------------------------------------------------- ---------- ------------ ------------
Operating Activities:
Net income (loss) $ (206,889) $ 127,278
Adjustments to reconcile net income (loss) to net cash provided
by operating activities:
Depreciation and amortization 91,026 78,600
Noncash restructuring and other nonrecurring costs, net (Note 7) 324,249 4,112
Provision for losses on accounts receivable (Note 7) 9,348 3,777
Change in deferred income taxes (46,643) (3,779)
Minority interest expense (income) (43,398) 40,766
Equity in loss of unconsolidated subsidiaries 10,663 474
Gain on issuance of stock by subsidiaries - (54,206)
Gain on sale of business (Note 7) (11,099) -
(Gain) loss on investments, net 699 (5,252)
Extraordinary item, net of income taxes and minority interest - (2,886)
Other noncash items 31,913 8,668
Changes in current accounts, excluding the effects of acquisitions and
dispositions:
Accounts receivable (7,007) 20,782
Inventories (11,784) (29,532)
Other current assets 4,527 (5,388)
Accounts payable (2,574) (21,453)
Other current liabilities (52,895) (29,751)
---------- -----------
Net cash provided by operating activities 90,136 132,210
---------- -----------
Investing Activities:
Acquisitions, net of cash acquired (Note 6) (345,214) (121,685)
Acquisition of Thermo Voltek common stock (Note 8) (20,482) -
Refund of acquisition purchase price 4,074 -
Proceeds from sale of a business 13,537 -
Purchases of available-for-sale investments (510,997) (1,484,823)
Proceeds from sale and maturities of available-for-sale 983,324 1,073,609
investments
Purchases of property, plant, and equipment (64,248) (74,226)
Proceeds from sale of property, plant, and equipment 14,540 8,994
Increase in other assets (6,687) (6,795)
Other 15,371 9,036
---------- -----------
Net cash provided by (used in) investing activities $ 83,218 $ (595,890)
---------- -----------
6
<PAGE>
THERMO ELECTRON CORPORATION
Consolidated Statement of Cash Flows (continued)
(Unaudited)
Six Months Ended
July 3, July 4,
(In thousands) 1999 1998
- ------------------------------------------------------------------------- ------ ------------ ------------
Financing Activities:
Net proceeds from issuance of long-term obligations $ 14,930 $ 243,973
Repayment of long-term obligations (20,005) (44,618)
Net proceeds from issuance of Company and subsidiary common 4,066 474,060
stock
Purchases of Company and subsidiary common stock and (140,370) (165,874)
subordinated convertible debentures
Redemption of subsidiary common stock (17,070) -
Decrease in short-term notes payable (10,516) (26,041)
Other 1,959 2,178
----------- ------------
Net cash provided by (used in) financing activities (167,006) 483,678
----------- ------------
Exchange Rate Effect on Cash (16,154) (2,628)
----------- ------------
Increase (Decrease) in Cash and Cash Equivalents (9,806) 17,370
Cash and Cash Equivalents at Beginning of Period 396,670 593,580
----------- ------------
Cash and Cash Equivalents at End of Period $ 386,864 $ 610,950
=========== ============
Noncash Activities:
Conversions of subsidiary convertible obligations $ - $ 16,980
=========== ============
Fair value of assets of acquired companies $ 588,437 $ 198,278
Cash paid for acquired companies (386,026) (132,568)
Issuance of subsidiary common stock for acquired company - (8,250)
----------- ------------
Liabilities assumed of acquired companies $ 202,411 $ 57,460
=========== ============
The accompanying notes are an integral part of these consolidated financial
statements.
7
<PAGE>
Notes to Consolidated Financial Statements
1. General
The interim consolidated financial statements presented have been prepared
by Thermo Electron Corporation (the Company) without audit and, in the opinion
of management, reflect all adjustments of a normal recurring nature necessary
for a fair statement of the financial position at July 3, 1999, the results of
operations for the three- and six-month periods ended July 3, 1999, and July 4,
1998, and the cash flows for the six-month periods ended July 3, 1999, and July
4, 1998. Certain prior period amounts have been reclassified to conform to the
presentation in the current financial statements. Interim results are not
necessarily indicative of results for a full year.
The consolidated balance sheet presented as of January 2, 1999, has been
derived from the consolidated financial statements that have been audited by the
Company's independent public accountants. The consolidated financial statements
and notes are presented as permitted by Form 10-Q and do not contain certain
information included in the annual financial statements and notes of the
Company. The consolidated financial statements and notes included herein should
be read in conjunction with the financial statements and notes included in the
Company's Annual Report on Form 10-K for the fiscal year ended January 2, 1999,
filed with the Securities and Exchange Commission.
2. Comprehensive Income
Comprehensive income combines net income (loss) and "other comprehensive
items," which represents certain amounts that are reported as components of
shareholders' investment in the accompanying balance sheet, including foreign
currency translation adjustments and unrealized net of tax gains and losses on
available-for-sale investments. During the second quarter of 1999 and 1998, the
Company had a comprehensive loss of $247.9 million and comprehensive income of
$57.9 million, respectively. During the first six months of 1999 and 1998, the
Company had a comprehensive loss of $257.0 million and comprehensive income of
$120.1 million, respectively.
</TABLE>
<TABLE>
<CAPTION>
3. Other Income (Expense), Net
The components of other income (expense), net in the accompanying
statement of operations are:
<S> <C> <C> <C> <C>
Three Months Ended Six Months Ended
July 3, July 4, July 3, July 4,
(In thousands) 1999 1998 1999 1998
- ------------------------------------------------------------- ---------- ----------- ---------- ----------
Interest Income $13,960 $ 28,464 $31,919 $ 52,229
Interest Expense (27,788) (26,360) (55,474) (51,967)
Equity in Loss of Unconsolidated Subsidiaries (Notes 6 an 7) (10,699) (186) (10,663) (474)
Gain (Loss) on Investments, Net (Note 7) (3,469) 5,412 (699) 5,252
Other (Note 7) (6,287) (3) (6,766) (82)
------- -------- ------- --------
$(34,283) $ 7,327 $(41,683) $ 4,958
======== ======== ======== ========
8
<PAGE>
4. Earnings (Loss) per Share
Basic and diluted earnings (loss) per share were calculated as follows:
Three Months Ended Six Months Ended
July 3, July 4, July 3, July 4,
(In thousands except per share amounts) 1999 1998 1999 1998
- ------------------------------------------------------------- ---------- ----------- ---------- ----------
Basic
Net Income (Loss) $(235,188) $ 61,785 $(206,889) $ 127,278
--------- ---------- --------- ---------
Weighted Average Shares 158,010 166,168 158,028 162,650
--------- --------- --------- ---------
Basic Earnings (Loss) per Share $ (1.49) $ .37 $ (1.31) $ .78
========= ========= ========= =========
Diluted
Net Income (Loss) $(235,188) $ 61,785 $(206,889) $ 127,278
Effect of:
Convertible obligations - 3,667 - 7,334
Majority-owned subsidiaries' dilutive securities (679) (2,500) (1,483) (6,676)
--------- --------- -------- ---------
Income (Loss) Available to Common Shareholders, $(235,867) $ 62,952 $(208,372) $ 127,936
as Adjusted
--------- --------- --------- ---------
Weighted Average Shares 158,010 166,168 158,028 162,650
Effect of:
Convertible obligations - 15,476 - 15,476
Stock options - 1,685 - 1,829
-------- --------- -------- ---------
Weighted Average Shares, as Adjusted 158,010 183,329 158,028 179,955
-------- --------- -------- ---------
Diluted Earnings (Loss) per Share $ (1.49) $ .34 $ (1.32) $ .71
========= ========= ========= =========
The computation of diluted loss per share for the second quarter and first
six months of 1999 excludes the effect of assuming the conversion of the
Company's $585.0 million principal amount 4 1/4% subordinated convertible
debentures, convertible at $37.80 per share, and the effect of assuming the
exercise of outstanding stock options, because the effect would be antidilutive
due to the Company's net loss. As of July 3, 1999, there were 11,952,000 of such
options outstanding, with exercise prices ranging from $8.85 to $43.46 per
share. In addition, the computation of diluted loss per share for the second
quarter and first six months of 1999 excludes the effect of assuming the
repurchase of 5,701,000 shares of Company common stock at a weighted average
exercise price of $14.56 per share in connection with put options sold to an
institutional counterparty, because the effect would be antidilutive.
During 1998, the Company recorded extraordinary gains in connection with
the repurchase of subsidiary subordinated convertible debentures, which
increased basic and diluted earnings per share by $.01 in the second quarter of
1998 and $.02 in the first six months of 1998.
9
<PAGE>
</TABLE>
<TABLE>
<CAPTION>
5. Business Segment Information
<S> <C> <C> <C> <C>
Three Months Ended Six Months Ended
July 3, July 4, July 3, July 4,
(In thousands) 1999 1998 1999 1998
- ---------------------------------------------------------- ----------- ----------- ----------- -----------
Revenues:
Measurement and Detection $ 588,502 $ 451,688 $1,105,266 $ 913,724
Biomedical and Emerging Technologies 242,864 228,293 479,193 451,555
Energy and Environment 196,467 192,369 380,747 379,361
Recycling and Resource Recovery 66,246 77,008 140,461 150,320
Intersegment (a) (1,739) (1,559) (3,789) (2,898)
---------- ---------- ---------- ----------
$1,092,340 $ 947,799 $2,101,878 $1,892,062
========== ========== ========== ==========
Income (Loss) Before Income Taxes, Minority Interest,
and Extraordinary Item:
Measurement and Detection (b) $ 29,300 $ 65,700 $ 82,894 $ 132,434
Biomedical and Emerging Technologies (c) (157,094) 17,328 (155,094) 35,860
Energy and Environment (d) (175,236) 20,556 (166,627) 28,197
Recycling and Resource Recovery (e) (24,120) 9,400 (9,358) 17,275
---------- ---------- ---------- ----------
Total segment income (f) (327,150) 112,984 (248,185) 213,766
Corporate (g) (43,188) 14,428 (58,835) 43,279
---------- ---------- ---------- ----------
$ (370,338) $ 127,412 $ (307,020) $ 257,045
========== ========== ========== ==========
(a) Intersegment sales are accounted for at prices that are representative of
transactions with unaffiliated parties.
(b) Includes restructuring and other nonrecurring costs of $30.4 million, $1.4
million, $31.6 million, and $1.4 million in the second quarter of 1999 and
1998, and the first six months of 1999 and 1998, respectively. Includes
charges of $3.0 million and $7.6 million in the second quarter and first six
months of 1999, respectively, primarily for the sale of inventories revalued
in connection with an acquisition and other inventory provisions.
(c) Includes restructuring and other nonrecurring costs of $142.3 million, $2.7
million, $145.1 million, and $2.7 million in the second quarter of 1999 and
1998, and the first six months of 1999 and 1998, respectively. Includes
charges of $20.2 million and $22.6 million in the second quarter and first
six months of 1999, respectively, primarily for inventory provisions.
(d) Includes restructuring and other nonrecurring costs of $189.2 million and
$189.9 million in the second quarter and first six months of 1999,
respectively. Includes charges of $4.4 million in the second quarter and
first six months of 1999, primarily for inventory provisions.
(e) Includes restructuring and other nonrecurring costs, net of $29.4 million
and $21.7 million in the second quarter and first six months of 1999,
respectively.
(f) Segment income is income before corporate general and administrative
expenses, other income and expense, minority interest, income taxes, and
extraordinary item.
(g) Includes corporate general and administrative expenses, other income and
expense, and in 1998, gain on issuance of stock by subsidiaries.
10
<PAGE>
6. Acquisitions
During the first quarter of 1999, Thermo Instrument acquired 17,494,684
shares (or approximately 99%) of Spectra-Physics AB, a Stockholm Stock
Exchange-listed company, for approximately 160 Swedish krona per share
(approximately $20 per share) in completion of Thermo Instrument's cash tender
offer to acquire all of the outstanding shares of Spectra-Physics. Thermo
Instrument expects to acquire the remaining Spectra-Physics shares outstanding
for approximately 160 Swedish krona per share pursuant to the compulsory
acquisition rules applicable to Swedish companies, of which certain shares were
acquired in the second quarter of 1999. The aggregate purchase price was
approximately $347.2 million, including related expenses. On the date of
acquisition, Spectra-Physics had $39.1 million of cash, which included $30.5
million held by its majority-owned subsidiary. The accompanying July 3, 1999,
balance sheet includes $2.2 million accrued for the purchase of the remaining
Spectra-Physics shares outstanding. Spectra-Physics manufactures a wide range of
laser-based instrumentation systems, primarily for the process-control,
industrial measurement, construction, research, commercial, and government
markets. Spectra-Physics had revenues of approximately $442 million in 1998,
with operations throughout North America and Europe, and a presence in the
Pacific Rim.
In connection with the acquisition of Spectra-Physics, Thermo Instrument
acquired 4,162,000 shares of FLIR Systems, Inc. common stock. FLIR designs,
manufactures, and markets thermal imaging and broadcast camera systems which
detect infrared radiation or heat emitted directly by all objects and materials.
The investment in FLIR shares represented 29.4% of FLIR's outstanding shares as
of July 3, 1999. Thermo Instrument accounts for its investment in FLIR on the
equity method with a one quarter lag to ensure the availability of FLIR's
operating results in time to enable Thermo Instrument to include its pro rata
share of FLIR's results with its own. During the first calendar quarter of 1999,
FLIR recorded a loss in connection with a pooling-of-interests transaction and
certain restructuring actions. Thermo Instrument has recorded its pro rata share
of this loss, $5.1 million, in equity in loss of unconsolidated subsidiaries, a
component of other income (expense), net in the accompanying statement of
operations. In addition, as a result of the pooling consummated by FLIR and
related issuance of FLIR shares in March 1999, Thermo Instrument's pro rata
share of FLIR's equity decreased. This decrease totaled $6.0 million and has
been recorded as a nonrecurring loss in equity in loss of unconsolidated
subsidiaries in the accompanying statement of operations, pursuant to Securities
and Exchange Commission Staff Accounting Bulletin 51.
In addition, the Company and its majority-owned subsidiaries made several
other acquisitions during the first six months of 1999 for $37.1 million in
cash, net of cash acquired, subject to certain post-closing adjustments. To
date, no information has been gathered that would cause the Company to believe
that the post-closing adjustments will be material.
These acquisitions have been accounted for using the purchase method of
accounting, and their results have been included in the accompanying financial
statements from their respective dates of acquisition. The aggregate cost of
these acquisitions exceeded the estimated fair value of the acquired net assets
by $157.1 million, which is being amortized over periods not exceeding 40 years.
Allocation of the purchase price for these acquisitions was based on estimates
of the fair value of the net assets acquired and is subject to adjustment upon
finalization of the purchase price allocations. The Company has gathered no
information that indicates the final allocations will differ materially from the
preliminary estimates. Pro forma results have not been presented as the results
of the acquired businesses were not material to the Company's results of
operations.
The Company has undertaken restructuring activities at certain acquired
businesses. The Company's restructuring activities, which were accounted for in
accordance with Emerging Issues Task Force Pronouncement (EITF) 95-3, primarily
have included reductions in staffing levels and the abandonment of excess
facilities. In connection with these restructuring activities, as part of the
cost of acquisitions, the Company established reserves, primarily for severance
and excess facilities. In accordance with EITF 95-3, the Company finalizes its
restructuring plans no later than one year from the respective dates of the
acquisitions. Unresolved matters at July 3, 1999, primarily included completion
of planned severances and abandonment of excess facilities for certain
acquisitions
11
<PAGE>
6. Acquisitions (continued)
completed during the last twelve months. A summary of the changes in accrued
acquisition expenses, which are included in other accrued expenses in the
accompanying balance sheet, follows:
</TABLE>
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C>
Abandonment
of Excess
(In thousands) Severance Facilities Other Total
- ----------------------------------------------- -------------- -------------- -------------- -------------
Balance at January 2, 1999 $ 7,347 $14,577 $ 1,268 $23,192
Reserves established 15,804 1,938 1,024 18,766
Usage (5,013) (1,736) (973) (7,722)
Decrease due to finalization of (455) - (242) (697)
restructuring plans, recorded as a
decrease to cost in excess of net assets
of acquired companies
Currency translation (597) (592) (89) (1,278)
------- ------- ------- -------
Balance at July 3, 1999 $17,086 $14,187 $ 988 $32,261
======= ======= ======= =======
7. Restructuring and Related Costs
During the second quarter of 1999, the Company and certain of its
subsidiaries initiated broad scale restructuring actions affecting a number of
business units. As a result, the Company recorded restructuring and related
costs totaling $418.8 million and other nonoperating charges totaling $24.9
million. Restructuring and related costs include $369.9 million of restructuring
costs, $21.4 million of other nonrecurring costs, $25.3 million of inventory and
warranty provisions, and $2.3 million of provisions for uncollectible accounts
receivable. The inventory and warranty provisions are included in cost of
revenues, and the provisions for uncollectible accounts receivable are included
in selling, general, and administrative expenses in the accompanying statement
of operations. Other nonoperating charges include $22.5 million of other
expense, net and $2.5 million of income tax expense as detailed by segment
below. Severance and lease costs, recorded as components of restructuring costs,
were accounted for in accordance with EITF 94-3.
In addition, during the first quarter of 1999, the Company and certain of
its subsidiaries recorded restructuring and related costs of $4.0 million,
including $5.6 million of restructuring costs, $8.6 million of other
nonrecurring income, net, and $7.0 million of inventory charges.
12
<PAGE>
</TABLE>
<TABLE>
<CAPTION>
7. Restructuring and Related Costs (continued)
The Company recorded charges by segment for the second quarter of 1999 as
follows:
<S> <C> <C> <C> <C> <C> <C>
(In thousands) Measurement Biomedical Energy Recycling Corporate Total
and and and and
Detection Emerging Environment Resource
Technologies Recovery
- --------------------- -------------- ------------- ------------- ------------- -------------- ------------
Cost of product and $ 2,957 $ 18,176 $ 4,129 $ - $ - $ 25,262
service revenues
Selling, general, - 2,049 249 - - 2,298
and administrative
expenses
Restructuring and 30,378 142,285 189,159 29,436 - 391,258
other nonrecurring
costs, net
Other expense, net 11,066 5,668 2,125 - 3,609 22,468
Income tax expense 1,409 - 1,055 - - 2,464
--------- -------- -------- -------- --------- --------
$ 45,810 $168,178 $196,717 $ 29,436 $ 3,609 $443,750
========= ======== ======== ======== ========= ========
The Company recorded charges by segment for the first six months of 1999
as follows:
(In thousands) Measurement Biomedical Energy Recycling Corporate Total
and and and and
Detection Emerging Environment Resource
Technologies Recovery
- --------------------- -------------- ------------- ------------- ------------- -------------- ------------
Cost of product and $ 7,566 $ 20,601 $ 4,129 $ - $ - $ 32,296
service revenues
Selling, general, - 2,049 249 - - 2,298
and administrative
expenses
Restructuring and 31,621 145,090 189,860 21,720 - 388,291
other nonrecurring
costs, net
Other expense, net 11,066 5,668 2,125 - 3,609 22,468
Income tax expense 1,409 - 1,055 - - 2,464
--------- -------- -------- -------- --------- --------
$ 51,662 $173,408 $197,418 $ 21,720 $ 3,609 $447,817
========= ======== ======== ======== ========= ========
The components of restructuring and related costs by segment and, where
applicable, by majority-owned subsidiary, are as follows:
Measurement and Detection
Thermedics Inc.
Thermedics recorded restructuring and related costs of $32.5 million
during the second quarter of 1999 relating to the Measurement and Detection
segment, including restructuring costs of $30.1 million, other nonrecurring
costs of $0.1 million, a tax asset write-off of $1.4 million, and inventory
provisions of $0.9 million. Restructuring costs of $30.1 million relate to a
decision to sell its power electronics and test equipment business and include
$28.5 million to write off related cost in excess of net assets of acquired
companies to reduce the carrying value of the business to the
13
<PAGE>
7. Restructuring and Related Costs (continued)
estimated proceeds from its sale. In addition, restructuring costs include a
charge of $1.6 million recorded by Thermedics to write off its remaining net
investment in a subsidiary of the power electronics and test equipment business,
which Thermedics intends to transfer to a buyer in consideration for a release
from certain contractual obligations, primarily ongoing lease obligations. The
tax write-off represents a deferred tax asset that will not be realized as a
result of exiting this business. The inventory provision results from exiting
and reengineering certain product lines. Unaudited revenues and operating
losses, excluding restructuring and related costs, of the power electronics and
test equipment business were $12.8 million and $0.9 million, respectively, for
the first six months of 1999 and $37.9 million and $0.2 million, respectively,
for 1998. Thermedics recorded other nonrecurring costs of $0.1 million to write
off a receivable as a result of an unfavorable resolution of a post-closing
adjustment in connection with the sale of a business in 1998.
Thermo Instrument Systems Inc.
In connection with restructuring actions commenced in 1998, certain
subsidiaries of Thermo Instrument recorded restructuring costs of $0.2 million
and $1.2 million during the second and first quarter of 1999, respectively. The
restructuring costs were primarily for business relocation and facility-closure
costs. Thermo Instrument expects to incur additional restructuring costs
totaling $0.8 million in the third quarter of 1999.
During the second quarter of 1999, Thermo Instrument recorded other
nonrecurring charges of $13.1 million, including $11.1 million in charges
relating to its equity investment in FLIR (Note 6). These charges were recorded
to equity in loss of unconsolidated subsidiaries, a component of other expense,
net in the accompanying statement of operations. Thermo Instrument's
nonrecurring charges also include an adjustment to cost of revenues of $2.0
million relating to the sale of inventories at Spectra-Physics revalued at the
date of its acquisition. Thermo Instrument recorded a charge of $4.6 million
relating to the sale of such inventories in the first quarter of 1999.
Biomedical and Emerging Technologies
ThermoTrex Corporation
During the second quarter of 1999, ThermoTrex announced restructuring
actions at its Trex Medical Corporation and ThermoLase Corporation subsidiaries.
In connection with these actions, ThermoTrex recorded restructuring and related
costs of $93.9 million in the second quarter of fiscal 1999, including
restructuring costs of $72.3 million, inventory and warranty provisions of $14.3
million, provisions for uncollectible accounts receivable of $1.6 million, and
other nonoperating charges of $5.7 million.
During the second quarter of 1999, Trex Medical recorded $18.1 million of
restructuring and related costs, including restructuring costs of $6.1 million
and inventory and warranty provisions of $12.0 million. The restructuring costs
were incurred primarily in connection with the consolidation of certain
facilities and, to a lesser extent, actions to reduce costs in other operations.
Restructuring costs include $2.3 million for facility-closing costs, net of
assumed sublease income; $2.0 million to write off leasehold improvements at
facilities to be closed and to write down fixed assets to their estimated
disposal value; and $1.9 million for severance for 265 employees across all
functions.
In August 1999, Trex Medical received notification from the FDA denying
its 501(k) filing for its digital mammography system. Trex Medical plans to meet
with the FDA to discuss the reasons for the denial, and expects to implement
various design changes, initiate additional clinical trials, and, if appropriate
after completing such clinical trials, submit a new application for marketing
clearance. Trex Medical hopes to have initiated additional clinical trials
within one year, but there can be no assurance regarding the timing or results
of such clinical trials, or the submission of a new filing to the FDA for
marketing clearance. Trex Medical recorded costs of $9.4 million to establish
inventory provisions and to terminate purchase commitments for products that
have become obsolete due to planned product
14
<PAGE>
7. Restructuring and Related Costs (continued)
changes or excess as a result of a recent decline in demand. The largest
component of the inventory charge was recorded as a result of the decision by
the FDA to deny Trex Medical's application its digital mammography system and
resulting design changes expected to be made to the system. Provisions resulting
from other planned product and technology changes and decreased demand for
certain other products are also principal components of the inventory charge.
Warranty provisions of $2.6 million were recorded for estimated costs to address
certain product warranty issues, including costs associated with corrective
actions to be taken with respect to certain previously sold mammography
products.
Trex Medical expects to incur additional restructuring costs totaling
approximately $5.0 million, principally over the next several quarters, which
will be recorded when incurred, such as additional charges for certain employee
and business relocation and related costs. Completion of Trex Medical's
restructuring plan is expected to occur in the first quarter of 2000.
During 1998, ThermoLase initiated certain restructuring activities,
including the announced closure of three domestic spas and the termination of a
joint venture that operated its spa in France. Two of the domestic spas were
closed during the fourth quarter of 1998. ThermoLase closed the third spa, as
well as two additional spas, in the second quarter of 1999. Also during the
second quarter of 1999, ThermoLase sold its remaining nine day spas, as well as
the stock in its destination spa, The Greenhouse Spa, Inc. In connection with
the sale and closures announced in 1999, as well as other actions, ThermoLase
recorded restructuring and related costs of $67.7 million during the second
quarter of 1999, including restructuring costs of $60.3 million, inventory
provisions of $2.3 million, provisions for uncollectible accounts receivable of
$1.7 million, and an investment write-down of $3.4 million. Restructuring costs
include a $19.9 million loss on the sale of its spa businesses; $17.4 million
for the write-off of leasehold improvements and equipment pertaining to the
hair-removal business; $11.7 million for ongoing lease obligations, net of
assumed sublease income; $10.0 million of estimated costs to terminate certain
other obligations related to the ThermoLase hair-removal business; $0.4 million
for losses on laser purchase commitments; $0.3 million to write down investments
in international joint ventures; and $0.4 million for other related costs. In
addition, restructuring costs include $0.2 million of severance costs for
approximately 14 employees across all functions. The inventory provisions were
for certain branded product lines at ThermoLase's Creative Beauty Innovations,
Inc. subsidiary that have been discontinued, and the investment write-down was
to reduce the carrying value of ThermoLase's investment in a privately held
company to its estimated disposal value. The investment write-down is included
in other expense, net in the accompanying statement of operations. Unaudited
revenues and operating losses, excluding restructuring costs, of the spa
businesses were $6.6 million and $15.5 million, respectively, for the first six
months of 1999, and $9.6 million and $14.6 million, respectively, for 1998.
ThermoTrex and the Company recorded aggregate restructuring costs of $62.7
million during the second quarter of 1999, representing a write-off of cost in
excess of net assets of acquired companies. Of the total write-off, $59.3
million was to write-off cost in excess of net assets of acquired companies that
arose from repurchases of ThermoLase common stock. This asset has become
impaired as a result of continuing losses at ThermoLase and a decision to exit
its principal business. The balance of the write off was recorded by ThermoTrex
as a result of a decision to hold for sale its Trex Communications Corporation
subsidiary, and represents a reduction in the carrying value of Trex
Communications to the amount of expected proceeds from its sale. In addition,
ThermoTrex provided a reserve of $2.3 million for impairment of a note
receivable from an unaffiliated company. This amount is included in other
expense, net in the accompanying statement of operations.
In addition, ThermoTrex recorded restructuring and related charges of $3.5
million during the first quarter of 1999, including $1.1 million of
restructuring costs, of which $0.6 million was recorded at Trex Medical. The
total charge also includes inventory provisions of $2.4 million that were
recorded by Trex Medical. The restructuring costs were related to severance for
72 employees across all functions.
15
<PAGE>
7. Restructuring and Related Costs (continued)
Thermo Coleman Corporation
Thermo Coleman Corporation recorded restructuring and related costs of
$17.0 million during the second quarter of 1999, principally as a result of a
decision to exit certain businesses through sale or closure. Restructuring costs
include $10.5 million to write off cost in excess of net assets of acquired
companies, $2.3 million for the write down of fixed assets, $3.8 million of
inventory provisions, and a $0.4 million provision for a note receivable. The
charges reduce the carrying values of the businesses to the estimated proceeds
from their sale. Unaudited revenues and operating losses of these businesses
were $16.5 million and $3.9 million, respectively, in the first six months of
1999, and revenues and operating income of $34.5 million and $1.5 million,
respectively, in 1998.
Thermedics Inc.
During the second quarter of 1999, Thermedics recorded $0.3 million of
other nonrecurring costs relating to the proposed transfer of the Company's
wholly owned Thermo Biomedical group of subsidiaries to Thermedics. In addition,
Thermedics recorded $1.4 million of other nonrecurring costs in the first
quarter of 1999, primarily for investment banking fees that were also associated
with the proposed transfer. Thermedics expects to incur additional nonrecurring
costs totaling approximately $0.7 million, principally through December 1999,
which will be recorded when incurred. These charges also relate to the proposed
transfer.
Other
The Company recorded restructuring costs of $0.2 million and $0.3 million
in the second and first quarter of 1999, respectively.
Energy and Environment
Thermo Ecotek Corporation
During the second quarter of 1999, Thermo Ecotek recorded $124.3 million
of restructuring costs and other charges of $2.1 million, as a result of actions
detailed below.
Following significant investments of resources in attempts to correct
operational problems, in May 1999, Thermo Ecotek made a decision to cease
further efforts and hold for sale or disposal its Gillette, Wyoming, facility.
As a result, Thermo Ecotek recorded a restructuring charge of $68.0 million,
including $63.3 million to write down the plant and related equipment to a
nominal salvage value, $4.4 million for estimated land reclamation costs, and
$0.3 million of other exit costs, primarily abandoned-facility payments. Thermo
Ecotek recorded $1.5 million of minority interest income, representing a
minority partner's share of these charges. Revenues of this facility were
nominal during the period it operated. The facility had unaudited operating
losses, excluding restructuring costs, of $6.2 million in the first six months
of 1999 and $7.6 million in 1998.
Thermo Ecotek's Delano, California, biomass facilities will reach the end
of the fixed price contract period of their power-sales agreement in September
2000. While Thermo Ecotek's forecasts for periods after that time project
positive cash flows, the facilities would operate at a loss due to depreciation
expense that extends beyond fiscal 2000. In May 1999, Thermo Ecotek entered into
an agreement to terminate the power-sales agreement for its Delano facilities,
effective December 31, 1999. The terms of the agreement call for Thermo Ecotek
to receive payments in lieu of operating under its current agreement and is
subject to regulatory approval. Thermo Ecotek recorded a restructuring charge of
$51.0 million as a result of entering into the new agreement, including $47.5
million to write down the plant and related assets to their estimated
recoverable value, $2.4 million related to a loss on the cancellation of the
facility's primary fuel contract, and $1.1 million to write off cost in excess
of net assets of acquired companies.
16
<PAGE>
7. Restructuring and Related Costs (continued)
Pacific Gas & Electric (PG&E), the customer under a long-term power-sales
agreement at Thermo Ecotek's Woodland, California, plant, has interpreted the
terms of such agreement to permit PG&E to cease payment of fixed contract rates
effective July 1, 1999, and to thereafter purchase power at avoided cost rates.
Although Thermo Ecotek contests this interpretation and is considering its
alternatives concerning this dispute, Thermo Ecotek recorded a restructuring
charge of $3.8 million during the second quarter of 1999, representing
impairment of its net investment in the Woodland facility as a result of PG&E's
decision to cease making payments of fixed contract rates.
In addition, during the second quarter of 1999, Thermo Ecotek recorded a
charge of $1.5 million to write off a power plant that is held for sale. Thermo
Ecotek believes that the salvage value, if any, is nominal.
In the second quarter of 1999, Thermo Ecotek also recorded a charge of
$2.1 million representing the write-down of available-for-sale investments
representing an equity interest of its minority partner in the Gillette,
Wyoming, facility due to impairment that Thermo Ecotek deems permanent based on
recent stock prices. This amount is included in loss on investments, net, a
component of other expense, net in the accompanying statement of operations.
Thermo TerraTech Inc.
In May 1999, Thermo TerraTech announced that its majority-owned
subsidiaries plan to sell several businesses. The businesses proposed to be sold
include the used-oil processing operation of Thermo EuroTech, N.V.; three
soil-recycling facilities of ThermoRetec Corporation, in addition to the sites
previously announced; and the Randers division, BAC Killam Inc., and E3-Killam
Inc. businesses of The Randers Killam Group Inc. In connection with these
actions, Thermo TerraTech recorded $55.9 million of restructuring and related
costs, including restructuring costs of $54.2 million, a tax asset write-off of
$1.1 million, and an inventory provision of $0.7 million. Restructuring costs
include $22.2 million to write down cost in excess of net assets of acquired
companies to reduce the carrying value of the businesses proposed to be sold to
the estimated proceeds from their sale; $20.2 million to write down fixed assets
to their estimated disposal value; $4.6 million for ongoing lease costs for
facilities that will be exited in connection with the sale of certain
businesses; $2.5 million for estimated land reclamation costs; $1.9 million to
write off the cumulative foreign translation adjustment related to Thermo
EuroTech's used-oil processing business; $1.8 million to write off intangible
assets related to license acquisition costs at the used-oil processing business;
$0.6 million for severance costs for 42 employees across all functions; and $0.4
million to write off other current assets associated with the businesses. The
tax asset write-off represents a deferred tax asset that will not be realized as
a result of selling Thermo EuroTech's used-oil processing business. The
inventory provision also relates to exiting this business. The write-down of
fixed assets principally relates to special purpose equipment in the used-oil
processing and soil-recycling businesses. In connection with the actions
discussed above, the Company also recorded $1.7 million to write down cost in
excess of net assets of acquired companies that arose in connection with the
Company's repurchases of Thermo EuroTech common stock. The write off is a result
of continuing losses and a decision to exit Thermo EuroTech's principal
business. Thermo TerraTech expects to incur additional restructuring costs of
approximately $3 million through the first half of 2000, for costs that will be
recorded when incurred, such as additional severance, employee retention, and
relocation expenses.
The businesses that are proposed to be sold reported aggregate unaudited
revenues and operating income, excluding restructuring and related costs, of
$22.3 million and $0.8 million, respectively, in the first six months of 1999
and aggregate unaudited revenues and operating losses of $54.3 million and $1.1
million, respectively, in 1998.
During 1998, Thermo TerraTech recorded restructuring costs, primarily
related to the closure or sale of two soil-recycling facilities by ThermoRetec.
ThermoRetec closed one soil-recycling facility in March 1999 and is actively
seeking a buyer for the second soil-recycling facility. If no buyer is found,
ThermoRetec will close the facility.
17
<PAGE>
7. Restructuring and Related Costs (continued)
Thermo Power Corporation
Thermo Power undertook certain restructuring actions during the second
quarter of 1999, which included a decision to divest its ThermoLyte Corporation
subsidiary, as well as a decision to outsource certain manufacturing and
warranty functions and reduce staffing levels at certain other subsidiaries. In
addition, Thermo Power wrote down certain assets at its Peek sales and service
subsidiaries located in Malaysia and Croatia that have become impaired due to
business conditions in those regions. In connection with these actions, Thermo
Power recorded restructuring and related costs of $12.6 million, including $8.9
million of restructuring costs, inventory provisions of $3.0 million, costs for
outsourcing certain warranty repairs of $0.5 million, and a provision for
uncollectible accounts receivable of $0.2 million. Restructuring costs include
$4.1 million for the write-off of cost in excess of net assets of acquired
companies, of which $2.9 million was to reduce the carrying value of ThermoLyte
to the estimated proceeds from its sale and $1.2 million was to reduce the
carrying value of Thermo Power's investment in its Peek subsidiaries located in
Malaysia and Croatia due to projected undiscounted cash flows from their
operations being insufficient to recover its investment. In addition,
restructuring costs include $2.0 million of severance costs for approximately 63
employees across all functions; $1.6 million for the write-down of certain fixed
assets, principally at operations being exited; and $1.2 million for lease costs
at facilities being abandoned. Inventory provisions represent a write-down of
inventories to estimated salvage value and consist of $1.9 million for raw
materials for product lines being outsourced, $1.0 million for a discontinued
product line, and $0.1 million for inventories at Peek's subsidiaries located in
Malaysia and Croatia. Unaudited revenues and operating losses for ThermoLyte,
excluding restructuring and related costs, were $7.0 million and $1.1 million,
respectively, in the first six months of fiscal 1999, and $5.8 million and $1.0
million, respectively, in 1998.
Thermo Power recorded restructuring costs of $0.7 million during the first
quarter of 1999 related to actions taken at its Peek subsidiary. The
restructuring costs consisted of $0.4 million of severance costs for
approximately 70 employees across all functions, $0.2 million for lease costs at
facilities being abandoned in connection with the consolidation of facilities,
and an asset write-down of $0.1 million related to the consolidation of such
facilities.
Thermo Power expects to incur additional restructuring costs totaling
approximately $2.5 million through December 1999 for costs that will be recorded
when incurred, such as additional severance costs and fees associated with
outsourcing certain product lines. Completion of Thermo Power's restructuring
plans is expected to occur by December 1999.
Recycling and Resource Recovery
Thermo Fibertek Inc.
Thermo Fibertek recorded $2.3 million of restructuring costs during the
first quarter of 1999, consisting of $1.3 million for severance costs for 24
employees across all functions, and $1.0 million to terminate distributor
agreements. In addition, Thermo Fibertek recorded other nonrecurring income, net
of $10.0 million, consisting of an $11.1 million gain on the sale of its Thermo
Wisconsin, Inc. subsidiary and $1.1 million of nonrecurring costs. The
nonrecurring costs consist of $0.5 million for the expected settlement of a
legal dispute, $0.3 million for the impairment of a building held for disposal,
and $0.3 million of other nonrecurring costs. Unaudited revenues and operating
income for Thermo Wisconsin were $1.8 million and $0.4 million, respectively, in
the first quarter of 1999, and $18.9 million and $2.6 million, respectively, in
1998.
18
<PAGE>
7. Restructuring and Related Costs (continued)
Other
In May 1999, a jury in the superior court of the state of Rhode Island
rendered a verdict against the Company in connection with an installation in
1985 of a wastewater treatment system by a subsidiary of the Company. The
plaintiff has submitted a brief to the court that sets forth a computation of
interest on the damages that, if approved by the court, would bring the total
amount of the award to approximately $21 million. The Company believes that both
the verdict and the interest computation are in error and intends to appeal. Due
to the inherent uncertainty of the appeal process, however, the Company has
recorded a charge of $21 million for this matter in the second quarter of 1999.
During the second quarter of 1999, the Company also decided to hold for
sale its Peter Brotherhood, Ltd. subsidiary. The Company recorded an $8.4
million write-down of fixed assets to reduce the carrying value of the business
unit to the estimated proceeds from its sale. Unaudited revenues and operating
income for Peter Brotherhood, excluding restructuring costs, were $22.9 million
and $0.9 million, respectively, in the first six months of 1999, and $41.7
million and $1.3 million, respectively, in 1998.
Corporate
During the second quarter of 1999, the Company recorded $3.6 million of
other nonoperating charges to write down available-for-sale investments due to
impairment that the Company deems permanent based upon recent market prices.
These charges are included in loss on investments, net, a component of other
expense, net in the accompanying statement of operations.
General
During 1998, certain subsidiaries announced restructuring actions that
included plans for termination of 792 employees. As of January 2, 1999, the
subsidiaries had terminated 550 employees. The restructuring actions in 1999
included plans for the termination of an additional 579 employees. During the
first six months of 1999, 373 employees were terminated in connection with the
restructuring plans announced in 1998 and 1999. A summary of the changes in
accrued restructuring costs, included in other accrued expenses in the
accompanying balance sheet, follows:
</TABLE>
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C>
Abandonment
(In thousands) Severance of Excess Other(a) Total
Facilities
------------------------------------------- -------------- -------------- -------------- -------------
Balance at January 2, 1999 $10,572 $5,437 $ 2,731 $18,740
Provision charged to expense 7,856 20,929 21,564 50,349
Usage (7,422) (3,246) (1,434) (12,102)
Currency translation (844) (167) (225) (1,236)
------- ------ ------- -------
Balance at July 3, 1999 $10,162 $22,953 $22,636 $55,751
======= ======= ======= =======
(a) Includes provisions in 1999 of $12.8 million for costs to terminate
contracts and $6.9 million for land reclamation costs.
8. Proposed Reorganization
During 1998, the Company announced a proposed reorganization, which was
amended in May 1999, involving the Company and certain of its subsidiaries. The
goals of the proposed reorganization include consolidating and strategically
realigning certain businesses to enhance their competitive market positions and
increasing liquidity in the public markets by providing larger market floats for
the Company's publicly traded subsidiaries.
19
<PAGE>
8. Proposed Reorganization(continued)
The Company plans to combine its wholly owned Thermo Biomedical group of
subsidiaries with Thermedics. The Company would transfer the Thermo Biomedical
group of subsidiaries to Thermedics. Thermedics Detection Inc. and Thermo
Sentron Inc. would be taken private. The public shareholders of Thermedics
Detection and Thermo Sentron would receive cash in exchange for their shares of
common stock of the respective companies. In addition, Thermedics' equity
interest in Thermo Sentron, Thermedics Detection, and Thermo Voltek Corp. would
be transferred to the Company and as a result each of Thermo Sentron, Thermedics
Detection, and Thermo Voltek would become wholly owned subsidiaries of the
Company. In March 1999, Thermedics acquired, through a merger, all of the
outstanding shares of Thermo Voltek common stock that Thermedics and the Company
did not already own. Subsequent to this transaction, Thermedics and the Company
owned approximately 97% and 3%, respectively, of the outstanding common stock of
Thermo Voltek, which ceased to be publicly traded.
In May 1999, Thermo Power entered into a definitive agreement and plan of
merger with the Company pursuant to which the Company would acquire, for $12.00
per share, all of the outstanding shares of common stock of Thermo Power not
already owned by the Company. Following the merger, Thermo Power's common stock
would cease to be publicly traded. This merger is expected to be completed in
the fourth quarter of calendar 1999.
In May 1999, ThermoSpectra Corporation entered into a definitive agreement
and plan of merger with Thermo Instrument pursuant to which Thermo Instrument
would acquire, for $16.00 per share, all of the outstanding shares of common
stock of ThermoSpectra not already owned by Thermo Instrument or the Company. In
July 1999, Thermo Vision Corporation entered into a definitive agreement and
plan of merger with Thermo Instrument pursuant to which Thermo Instrument would
acquire, for $7.00 per share, all of the outstanding shares of Thermo Vision not
already owned by Thermo Instrument or the Company. Following the mergers,
ThermoSpectra's and Thermo Vision's common stock would cease to be publicly
traded. Both of these mergers are expected to be completed in the fourth quarter
of 1999.
Thermo TerraTech, ThermoRetec, The Randers Killam Group, ThermoTrex,
ThermoLase, and Thermo Ecotek would merge into the Company. Shareholders of each
of these companies would receive shares of common stock of the Company in
exchange for their shares of common stock of the respective companies.
The completion of the merger of Thermo Voltek into Thermedics reduced the
number of the Company's majority-owned subsidiaries to 23. If the reorganization
plan is completed as proposed, it would further reduce the number of the
Company's majority-owned subsidiaries from 23 to 12. Each component of the
reorganization is subject to numerous conditions, including the following (not
all of which are applicable to each component): establishment of prices and/or
exchange ratios; confirmation of anticipated tax consequences; approval by the
boards of directors (including the outside directors) of each of the affected
majority-owned subsidiaries; negotiation and execution of definitive purchase
and sale or merger agreements; completion of review by the Securities and
Exchange Commission of any necessary documents regarding the proposed
transactions; and fairness opinions from one or more investment banking firms on
certain financial aspects of the transactions. One or more of the transactions
may not occur if the applicable conditions previously described are not
satisfied.
Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking statements, within the meaning of Section 21E of the
Securities Exchange Act of 1934, are made throughout this Management's
Discussion and Analysis of Financial Condition and Results of Operations. For
this purpose, any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. Without limiting
the foregoing, the words "believes," "anticipates," "plans," "expects," "seeks,"
"estimates," and similar expressions are intended to identify forward-looking
statements. There are a number of important factors that could cause the results
of the Company to differ materially from those indicated by such forward-looking
statements, including those detailed under the heading "Forward-looking
Statements" in Exhibit 13 to the Company's Annual Report on Form 10-K for the
fiscal year ended January 2, 1999, filed with the Securities and Exchange
Commission.
20
<PAGE>
Results of Operations
Second Quarter 1999 Compared With Second Quarter 1998
Sales in the second quarter of 1999 were $1.09 billion, an increase of
$144.5 million, or 15%, over the second quarter of 1998. Excluding restructuring
and other nonrecurring costs, net of $391.3 million and $4.1 million in 1999 and
1998, respectively, described below, and inventory and other provisions of $27.6
million in 1999, segment income decreased to $91.7 million in 1999 from $117.1
million in 1998. (Segment income is income before corporate general and
administrative expenses, other income and expense, minority interest, income
taxes, and extraordinary item.) Operating loss, which includes restructuring and
other nonrecurring costs, net and inventory and other provisions, was $336.1
million in 1999, compared with operating income of $105.5 million in 1998.
Measurement and Detection
Sales from the Measurement and Detection segment increased $136.8 million,
or 30%, to $588.5 million in 1999. Sales increased due to acquisitions made by
Thermo Instrument Systems Inc. and Thermo Sentron Inc., which added $159.4
million of revenues in 1999. The unfavorable effects of currency translation,
due to the strengthening of the U.S. dollar relative to foreign currencies in
countries in which the Measurement and Detection segment operates, decreased
revenues by $4.2 million in 1999. Revenues from Thermo Instrument's analytical
products, excluding the effects of acquisitions and currency translation,
increased $10.8 million, primarily due to the introduction of new products and
an increase in revenues from sales to customers in Asia due to improved economic
conditions there. In addition, sales of life sciences products, excluding
acquisitions and currency translation, increased $3.3 million due to higher
demand and expansion of sales and distribution channels into new markets. The
increases in revenues from acquisitions and at certain existing businesses were
offset in part by lower revenues from other businesses. Revenues from Thermo
Instrument's industrial products, excluding the effects of acquisitions and
currency translation, decreased $13.1 million, primarily due to lower revenues
at ThermoSpectra Corporation's existing businesses as a result of continued
weakness in the semiconductor industry. Revenues from Thermo Instrument's
process control products, excluding acquisitions and currency translation,
decreased $11.2 million as a result of a reduction in discretionary capital
spending by companies in the process control industry due to difficult market
conditions and, to a lesser extent, a reduction in spending by raw materials
producers. Revenues from this segment's quality assurance and safety products
business decreased $5.8 million due to lower demand. Revenues from this
segment's power electronics and test equipment business decreased $4.2 million
due to lower demand and the sale of a business unit which had sales of $1.6
million in the prior period. There can be no assurance that the trends that have
adversely affected this segment will not continue.
Segment income margin (segment income margin is segment income as a
percentage of sales), excluding restructuring and other nonrecurring costs of
$30.4 million in 1999 and $1.4 million in 1998, decreased to 10.1% in 1999 from
14.9% in 1998. Excluding charges for the sale of inventories revalued at the
date of acquisition of $2.0 million and other inventory provisions of $0.9
million, segment income margin was 10.6% in 1999. Segment income margin
decreased primarily due to the effect of lower revenues at certain business
units and, to a lesser extent, the inclusion of lower-margin revenues from
Spectra-Physics AB, which was acquired in February 1999. This segment recorded
restructuring and other nonrecurring costs of $30.4 million in 1999 (Note 7),
principally as a result of a decision to hold for sale its power electronics and
test equipment business. The charge primarily represents a reduction in the
carrying value of this business to the expected proceeds from its sale. Thermo
Instrument expects to incur restructuring costs totaling approximately $0.8
million in the third quarter of 1999. In 1998, Thermo Instrument recorded $1.4
million of nonrecurring costs relating to the resolution of an arbitration
proceeding.
21
<PAGE>
Second Quarter 1999 Compared With Second Quarter 1998 (continued)
Biomedical and Emerging Technologies
Sales from the Biomedical and Emerging Technologies segment were $242.9
million in 1999, an increase of $14.6 million, or 6%, over the 1998 period.
Sales increased primarily due to the inclusion of $16.6 million of sales from
acquired businesses. In addition, sales at Thermo Cardiosystems Inc. increased
$4.1 million, or 25%, while sales of respiratory and monitoring products by the
Company's wholly owned Thermo Biomedical group increased $2.8 million due to
higher demand. In addition, revenues at Thermo Digital Technologies L.L.C.
increased due to continued shipments of digital passport printers under a
contract with the U.S. government that commenced in the third quarter of 1998.
These revenue increases were offset in part by lower revenues at Trex Medical
Corporation. Revenues at Trex Medical, excluding revenues from an acquired
business, decreased $13.1 million. Of this amount, $10.6 million resulted from
the termination of an original equipment manufacturer (OEM) contract with a
major customer following the customer's acquisition by another corporation. In
addition, Trex Medical had lower sales of general-purpose X-ray and
radiographic/fluoroscopic systems, offset in part by higher demand for
mammography systems and related upgrade components.
Segment loss, excluding restructuring and other nonrecurring costs of
$142.3 million in 1999 and $2.7 million in 1998, was $14.8 million in 1999,
compared with segment income of $20.0 million in 1998. This decline resulted
primarily from inventory and other provisions at several business units which
aggregated $20.2 million in 1999 (Note 7). Excluding these provisions, segment
income for the Biomedical and Emerging Technologies segment was $5.4 million in
1999. Trex Medical had a segment loss, excluding restructuring costs and other
provisions, of $1.5 million in 1999, compared with segment income of $9.6
million in the 1998 period. The decrease in profitability at Trex Medical was
primarily due to a large decrease in sales at existing businesses. The segment
loss at ThermoLase Corporation, excluding restructuring and nonrecurring costs
and other provisions, totaled $7.3 million in 1999, compared with $6.0 million
in 1998. ThermoLase sold The Greenhouse Spa, Inc., and nine of its day spas in
June 1999, and closed its remaining spas as a result of a decision to exit this
business. Thermo Coleman Corporation had a segment loss, excluding restructuring
costs and other provisions, of $2.3 million in 1999, compared with segment
income of $1.3 million in 1998. The segment loss resulted from losses at its
Thermo Information Solutions Inc.'s Internet services subsidiary and at its
Metric Vision subsidiary which commenced operations in the past year.
Restructuring and other nonrecurring costs of $142.3 million in 1999 (Note
7) includes $60.3 million of costs recorded by ThermoLase in connection with the
sale of its spas and exiting its hair-removal business; $59.3 million to
write-off cost in excess of net assets of acquired companies arising from
repurchases of ThermoLase stock; $12.7 million at Thermo Coleman and $3.4
million at ThermoTrex for the write-off of cost in excess of net assets of
acquired companies and fixed assets to reduce the carrying value of three
businesses to the estimated proceeds from their sale; $6.1 million at Trex
Medical for severance and abandoned leases resulting principally from the
consolidation of facilities; $0.3 million of nonrecurring costs at Thermedics
associated with the proposed transfer of the Company's wholly owned Thermo
Biomedical group of subsidiaries to Thermedics; and $0.2 million of other
severance costs. This segment expects to have additional restructuring costs of
approximately $5.7 million over the remainder of 1999. Restructuring costs of
$2.7 million in 1998 includes $1.9 million recorded by ThermoLase in connection
with certain actions, including the relocation of its headquarters from
California to Texas, and $0.8 million recorded by SensorMedics Corporation in
connection with the reorganization of a subsidiary in the Netherlands.
Energy and Environment
Sales from the Energy and Environment segment increased $4.1 million to
$196.5 million in 1999. Revenues from Thermo Ecotek Corporation increased $1.5
million in 1999 to $52.3 million. The increase results from the expansion of an
existing power generation facility and two facilities placed in service during
the quarter for the summer peak season. These increases were offset in part by
lower revenues at Thermo Ecotek's Thermo Trilogy Corporation biopesticide
subsidiary due to lower demand. As noted below, the periods during which Thermo
Ecotek receives fixed rates for power at these facilities has ended or will end
in 2000. The change from fixed rates to avoided cost rates under the terms of
the contracts, as discussed below, will have a significant adverse effect on
Thermo
22
<PAGE>
Second Quarter 1999 Compared With Second Quarter 1998 (continued)
Ecotek's revenues and profitability. Sales at Thermo Power Corporation increased
$3.4 million in 1999 to $68.3 million, principally due to revenues of $3.1
million from an acquired business and higher demand for gas-fueled cooling
systems and standard industrial refrigeration packages. These increases were
offset in part by a $7.0 million decrease in Thermo Power's revenues as a result
of the sale of its Crusader Engines division in December 1998. Revenues at
Thermo TerraTech Inc. decreased slightly to $75.9 million in 1999 from $76.7
million in 1998.
Segment income, excluding restructuring costs of $189.2 million in 1999,
was $13.9 million in 1999, compared with $20.6 million in 1998. Excluding
provisions for inventories and other charges of $4.4 million, segment income was
$18.3 million in 1999. Thermo Ecotek's segment income before restructuring costs
in 1999 was $8.8 million in 1999, compared with $10.5 million in 1998. The
decrease resulted principally from a loss of $0.3 million at Thermo Trilogy in
1999, compared with income of $0.9 million in 1998, due to lower revenues.
Segment income at Thermo Power, excluding restructuring costs and other charges
in 1999, was $3.8 million in 1999 and $5.4 million in 1998. The decrease
occurred primarily at Thermo Power's Peek plc subsidiary as a result of a change
in sales mix and higher research and development costs. Segment income before
restructuring costs and other charges in 1999 at Thermo TerraTech increased to
$5.7 million in 1999 from $4.7 million in 1998. The increase at Thermo TerraTech
principally resulted from lower depreciation and amortization as a result of
recording write-offs and writedowns during the second quarter of 1999.
Restructuring costs of $189.2 million in 1999 (Note 7) include $124.4
million at Thermo Ecotek resulting principally from a decision to close its
coal-beneficiation facility and from impairment of its Delano facility following
an agreement to terminate the power-sales agreement for that facility.
Restructuring costs in 1999 also include $8.9 million at Thermo Power resulting
principally from a decision to hold for sale its ThermoLyte subsidiary,
impairment at two sales and service businesses of its Peek subsidiary that
operate in Malaysia and Croatia, and staff reductions and facility
consolidations at other Peek units. Restructuring costs in 1999 at Thermo
TerraTech totaled $54.2 million and result from decisions to sell several
businesses. The charges at Thermo TerraTech primarily reduce the carrying value
of the businesses to the expected proceeds from their sale. In addition, the
Company recorded $1.7 million of restructuring costs associated with cost in
excess of net assets of acquired companies arising from the Company's
repurchases of Thermo EuroTech stock, which has become impaired due to
continuing losses and a decision to exit its principal business. This segment
expects to incur additional restructuring costs of approximately $5.5 million
over the remainder of 1999.
The power-sales agreements for Thermo Ecotek's Mendota, Woodland, and
Delano plants in California are so-called standard offer #4 (SO#4) contracts,
which require Pacific Gas & Electric (PG&E), in the case of Mendota and
Woodland, and Southern California Edison (SCE), in the case of the Delano
facilities, to purchase the power output of the projects at fixed rates through
specified periods. Thereafter, the utility will pay a rate based upon the costs
that would have otherwise been incurred by the purchasing utilities in
generating their own electricity or in purchasing it from other sources (avoided
cost). Avoided cost rates are currently substantially lower than the rates
Thermo Ecotek has received under the fixed-rate portions of its contracts and
are expected to remain so for the foreseeable future. PG&E commenced paying for
power purchased from the Mendota and Woodland facilities at avoided cost rates
effective in June and July 1999, respectively, although Thermo Ecotek believes
that this change to avoided cost rates occurred six months earlier than the
power-sales agreements provided. Thermo Ecotek is considering its alternatives
concerning this dispute. Thermo Ecotek expects that at current avoided cost
rates its Mendota plant will operate at substantially reduced operating income
levels or at a loss beginning in the third quarter of 1999 and thereafter.
Further, based on current avoided cost rates, the Woodland plant will operate at
breakeven or nominal operating losses through 2010, primarily as a result of
nonrecourse lease obligations that have been partially funded from the Woodland
plant's past cash flows. Absent sufficient reductions in fuel prices and other
operating costs, Thermo Ecotek will draw down power reserve funds to cover
operating cash shortfalls and then, if such funds are depleted, either
renegotiate its nonrecourse lease for the Woodland plant or forfeit its interest
in the plant. The results of the Woodland facility were approximately breakeven
in 1999 and 1998, as a result of recording as an expense the funding of reserves
required under Woodland's nonrecourse lease agreement to cover expected
shortfalls in lease payments. The power-sales
23
<PAGE>
Second Quarter 1999 Compared With Second Quarter 1998 (continued)
agreement with SCE for the Delano facilities calls for fixed contract rates
through September 2000. If the agreement reached in May 1999 to terminate Thermo
Ecotek's power-sales agreements for its Delano facilities receives regulatory
approval, Thermo Ecotek expects that the results of the Delano facilities will
be reduced to breakeven or a nominal loss subsequent to December 1999. Should
the agreement not receive approval, Thermo Ecotek expects that its Delano
facilities will continue to have positive cash flows but will operate at
substantial operating losses beginning in the fourth quarter of 2000. In
calendar 1998, the Mendota and Delano plants' aggregate operating income was
approximately $41.7 million. In anticipation of these expected declines in
revenues and operating income, Thermo Ecotek may explore other options for its
biomass facilities, including disposal or repowering.
Recycling and Resource Recovery
Sales in the Recycling and Resource Recovery segment decreased to $66.2
million in 1999 from $77.0 million in 1998. Sales from Thermo Fibertek Inc.
decreased $10.0 million to $53.5 million in 1999, primarily due to the February
1999 sale of its Thermo Wisconsin, Inc. subsidiary that resulted in a decrease
in revenues of $5.7 million. Revenues at Thermo Fibertek's existing businesses
also decreased primarily due to lower sales of stock-preparation equipment in
Europe and North America and accessories in North America. These decreases were
offset in part by higher revenues from Thermo Fibergen Inc.'s water- and
fiber-recovery services. The unfavorable effects of currency translation
decreased revenues by $0.4 million in 1999.
Segment income, excluding restructuring and other nonrecurring costs, of
$29.4 million in 1999, was $5.3 million in 1999, compared with $9.4 million in
1998. Segment income decreased primarily at Thermo Fibertek as a result of a
decrease in revenues. Restructuring costs of $8.4 million were recorded at the
Company's wholly owned Peter Brotherhood subsidiary to write down property and
equipment to reduce the carrying value of this unit to the estimated proceeds
from its sale. In May 1999, a jury in the superior court of the state of Rhode
Island rendered a verdict against the Company in connection with an installation
in 1985 of a wastewater treatment system by the Company's wholly owned Napco
subsidiary. The plaintiff has submitted a brief to the court that sets forth a
computation of interest on the damages that, if approved by the court, would
bring the total amount of the award to approximately $21 million. The Company
believes that both the verdict and the interest computation are in error and
intends to appeal this matter. Due to the inherent uncertainty of the appeal
process, however, the Company has recorded a charge of $21 million for this
matter in 1999.
Gain on Issuance of Stock by Subsidiaries and Minority Interest Expense
The Company has, from time to time, caused certain subsidiaries to sell
minority interests to investors resulting in several majority-owned, privately
and publicly held subsidiaries. As a result of the sale of stock by subsidiaries
and the issuance of stock by subsidiaries upon conversion of convertible
debentures, the Company recorded gains of $14.6 million in 1998. The Company
recorded minority interest income of $47.5 million in 1999, primarily as a
result of restructuring and other nonrecurring costs at the Company's
majority-owned subsidiaries. Minority interest expense was $16.7 million in
1998. Minority interest expense in 1998 includes $1.9 million related to gains
recorded by the Company's majority-owned subsidiaries as a result of the sale of
stock by their subsidiaries and the issuance of stock by their subsidiaries upon
conversion of convertible debentures.
Income Taxes
The company's effective tax rate was a benefit of 24% in 1999. Excluding
nontaxable gains from issuance of subsidiary stock, the Company's effective tax
rate was 45% in 1998. The effective tax rates vary from the statutory federal
income tax rate primarily due to state income taxes and nondeductible expenses,
including in 1999, the write-off of cost in excess of net assets of acquired
companies. In addition, in connection with restructuring actions, certain
subsidiaries wrote off deferred tax assets aggregating $2.5 million in 1999
(Note 7).
24
<PAGE>
First Six Months 1999 Compared With First Six Months 1998
Sales in the first six months of 1999 were $2.10 billion, an increase of
$209.8 million, or 11%, over the first six months of 1998. Excluding
restructuring and other nonrecurring costs, net, of $388.3 million and $4.1
million in 1999 and 1998, respectively, described below, and inventory and other
provisions of $34.6 million in 1999, segment income decreased to $174.7 million
in 1999 from $217.9 million in 1998. Operating loss, which includes
restructuring and other nonrecurring costs, net and inventory and other
provisions, was $265.3 million in 1999, compared with operating income of $197.9
million in 1998.
Measurement and Detection
Sales from the Measurement and Detection segment increased $191.5 million
to $1.11 billion in 1999. Sales increased due to acquisitions made by Thermo
Instrument and Thermo Sentron, which added $259.6 million of revenues in 1999.
The favorable effects of currency translation, due to the decline in value of
the U.S. dollar relative to foreign currencies in countries in which the
Measurement and Detection segment operates, increased revenues by $1.3 million
in 1999. Increases in revenues from acquisitions and currency translation were
offset in part by lower revenues at existing businesses. Revenues from Thermo
Instrument's industrial products, excluding the effects of acquisitions and
currency translation, decreased $30.4 million, primarily due to lower revenues
at ThermoSpectra's existing businesses as a result of continued weakness in the
semiconductor industry. Revenues from Thermo Instrument's process control
products, excluding acquisitions and currency translation, decreased $20.4
million due to the reasons discussed in the results for the second quarter.
Revenues from this segment's quality assurance and safety products business
decreased $9.1 million due to lower demand and revenues at its power electronics
and test equipment business decreased $9.4 million due to lower demand and the
sale of a business unit which had revenues of $2.9 million in the 1998 period.
Segment income margin, excluding restructuring and other nonrecurring
costs of $31.6 million in 1999 and $1.4 million in 1998, decreased to 10.4% in
1999 from 14.6% in 1998. Excluding a charge for the sale of inventories revalued
at the date of acquisition of $6.7 million and other inventory provisions of
$0.9 million, segment income margin was 11.0% in 1999. The decrease was due to
the reasons discussed in the results for the second quarter. Restructuring and
other nonrecurring costs of $30.2 million in 1999 (Note 7) principally represent
a charge in connection with the planned sale of the segment's power electronics
and test equipment business, discussed in the results for the second quarter. In
connection with restructuring actions commenced in 1998, Thermo Instrument
recorded restructuring costs of $1.4 million in 1999, primarily for business
relocation and facility-closure costs and severance costs (Note 7). In 1998,
Thermo Instrument recorded $1.4 million of nonrecurring costs for the reason
discussed in the results of operations for the second quarter.
Biomedical and Emerging Technologies
Sales from the Biomedical and Emerging Technologies segment were $479.2
million in 1999, an increase of $27.6 million, or 6%, over the 1998 period.
Sales increased due to the inclusion of $45.9 million of sales from acquired
businesses. Sales at Thermo Cardiosystems increased $7.1 million, or 22%, due to
higher demand. In addition, revenues from government contracts at Thermo Coleman
increased, and revenues at Thermo Digital Technologies increased due to
continued shipments of digital passport printers under a contract with the U.S.
government that commenced in the third quarter of 1998. These increases were
offset in part by lower revenues at Trex Medical and, to a lesser extent, from a
decrease in sales of respiratory products at the Company's wholly owned Thermo
Biomedical group. Revenues at Trex Medical, excluding revenues from an
acquisition, decreased $35.9 million. Of this amount, $21.9 million resulted
from a reduction in revenues due to the termination of an OEM contract with a
major customer following the customer's acquisition by another corporation.
Revenues also decreased at Trex Medical due to the inclusion in the 1998 period
of a $8.8 million cardiac catheterization system sale to a Russian customer. In
addition, Trex Medical had lower sales of general-purpose X-ray and
radiographic/fluoroscopic systems, offset in part by higher demand for
mammography systems and related upgrade components. Revenues at Thermo
Biomedical decreased $4.4 million primarily due to lower international demand
for respiratory products.
25
<PAGE>
First Six Months 1999 Compared With First Six Months 1998 (continued)
Segment loss, excluding restructuring and other nonrecurring costs of
$145.1 million in 1999 and $2.7 million in 1998, was $10.0 million in 1999
compared with income of $38.5 million in 1998. This decline resulted primarily
from inventory and other provisions in 1999 at several business units which
aggregated $22.6 million (Note 7). Excluding these provisions, segment income at
the Biomedical and Emerging Technologies segment was $12.6 million in 1999. Trex
Medical had a segment loss, excluding restructuring costs and other provisions,
of $4.6 million in 1999, compared with segment income of $18.5 million in the
1998. The decrease in profitability at Trex Medical was due to the reason
discussed in the results for the second quarter. The segment loss at ThermoLase,
excluding restructuring costs and other provisions, totaled $13.5 million in
1999, compared with $13.9 million in 1998. Thermo Coleman had a segment loss,
excluding restructuring costs and inventory provisions, of $1.0 million in 1999,
compared with segment income of $2.1 million in 1998. The decrease in
profitability was primarily due to losses at its Metric Vision and Thermo
Information Solutions subsidiaries.
Restructuring and other nonrecurring costs of $145.1 million in 1999 (Note
7) principally includes the amounts described in the results for the second
quarter. In addition, $1.4 million of nonrecurring costs were recorded by
Thermedics in the first six months of 1999. These costs were associated with the
proposed transfer of the Company's wholly owned Thermo Biomedical group of
subsidiaries to Thermedics and primarily represent investment banking fees.
ThermoTrex, including Trex Medical, recorded $1.1 million of severance costs in
the first quarter of 1999 in addition to the further actions described in the
results for the second quarter. The Company also recorded $0.3 million of other
restructuring costs in 1999. Restructuring costs of $2.7 million in 1998
includes $1.9 million recorded by ThermoLase and $0.8 million recorded by
SensorMedics for the reasons discussed in the results of operations for the
second quarter.
Energy and Environment
Sales from the Energy and Environment segment were $380.7 million in 1999,
compared with $379.4 million in 1998. Revenues from Thermo Ecotek increased $1.6
million to $99.6 million in 1999. Thermo Ecotek's revenues changed for the
reasons discussed in the results of operations for the second quarter. Sales at
Thermo Power decreased $4.0 million to $129.5 million in 1999, principally due
to the sale of its Crusader Engines division in December 1998. Sales at Crusader
totaled $14.1 million in the first six months of 1998 and its results were
approximately breakeven. This decrease was offset in part by revenues of $6.8
million from an acquired business and higher demand for gas-fueled cooling
systems and standard industrial refrigeration packages. Revenues at Thermo
TerraTech increased $3.8 million to $151.7 million in 1999. Revenues from Thermo
TerraTech's environmental-liability management services increased $1.6 million
due to higher demand at certain business units and, to a lesser extent, the
inclusion of $0.7 million of sales from an acquired business. Revenues from
Thermo TerraTech's engineering and design services increased $1.8 million in
1999 due to an increase in demand for its laboratory services.
Segment income, excluding restructuring costs of $189.9 million in 1999,
was $23.2 million in 1999, compared with $28.2 million in 1998. Excluding
provisions for inventories and other charges, segment income was $27.6 million
in 1999. Thermo Ecotek's segment income before restructuring costs was $12.6
million in 1999, compared with $16.9 million in 1998. The change resulted from
$3.8 million of higher losses in the 1999 period from Thermo Ecotek's
coal-beneficiation facility which was closed in May 1999 and reduced
profitability at Thermo Trilogy due to lower revenues. Segment income at Thermo
Power, excluding restructuring costs and other charges in 1999, was $5.0 million
in 1999 and $6.7 million in 1998. Segment income decreased for the reasons
discussed in the second quarter, offset in part by the inclusion of income from
an acquisition. Segment income excluding restructuring costs and other charges
at Thermo TerraTech increased to $10.0 million in 1999 from $4.8 million in
1998. Segment income increased principally due to a loss of $5.4 million in 1998
at one of ThermoRetec's business units as a result of losses on certain
remedial-construction contracts. Restructuring costs of $124.4 million at Thermo
Ecotek, $54.2 million at Thermo TerraTech, and $1.7 million relating to the
Company's repurchases of Thermo EuroTech stock, are described in the results for
the second quarter. Restructuring costs of $9.6 million were recorded by Thermo
Power in 1999, principally for the actions described in the results for the
second quarter (Note 7).
26
<PAGE>
First Six Months 1999 Compared With First Six Months 1998 (continued)
Recycling and Resource Recovery
Sales in the Recycling and Resource Recovery segment decreased to $140.5
million in 1999 from $150.3 million in 1998. Sales at Thermo Fibertek decreased
$12.1 million to $113.8 million in 1999, primarily due to the February 1999 sale
of its Thermo Wisconsin subsidiary that resulted in a decrease in revenues of
$9.7 million. Lower revenues from stock-preparation equipment and accessories
was offset in part by higher revenues from water- and fiber- recovery services.
Revenues increased by $4.3 million at the Company's wholly owned Peter
Brotherhood subsidiary due principally to a contract to sell turbine generators
to a customer in Russia.
Segment income, excluding restructuring and other nonrecurring costs, net,
of $21.7 million in 1999, decreased to $12.4 million in 1999 from $17.3 million
in 1998. The decrease was primarily due to lower segment income at Thermo
Fibertek as a result of lower revenues and the sale of Thermo Wisconsin which
represented $1.2 million of the decrease. This decrease was offset in part by an
increase in segment income at Peter Brotherhood due to higher revenues.
Restructuring and other nonrecurring costs, net of $21.7 million included $21.0
million related to litigation and $8.4 million in connection with the planned
sale of Peter Brotherhood, as described in the results for the second quarter,
offset in part by nonrecurring income of $7.7 million at Thermo Fibertek. The
nonrecurring income at Thermo Fibertek consists of a gain on the sale of Thermo
Wisconsin of $11.1 million, offset in part by restructuring and other
nonrecurring costs of $3.4 million (Note 7).
Gain on Issuance of Stock by Subsidiaries and Minority Interest Expense
As a result of the sale of stock by subsidiaries and the issuance of stock
upon conversion of convertible debentures, the Company recorded gains of $54.2
million in 1998. The Company recorded minority interest income of $43.4 million
in 1999, primarily as a result of restructuring and other nonrecurring costs at
the Company's majority-owned subsidiaries. Minority interest expense in 1998
includes $14.3 million related to gains recorded by the Company's majority-owned
subsidiaries as a result of the sale of stock by their subsidiaries and the
issuance of stock by their subsidiaries upon conversion of convertible
debentures.
Income Taxes
The Company's effective tax rate in 1999 was a benefit of 18%. Excluding
nontaxable gains from issuance of subsidiary stock, the Company's effective tax
rate was 45% in 1998. The effective tax rates vary from the statutory federal
income tax rate primarily due to state income taxes and nondeductible expenses,
including in 1999, the write-off of cost in excess of net assets of acquired
companies. In addition, in connection with restructuring actions, certain
subsidiaries wrote off deferred tax assets aggregating $2.5 million in 1999
(Note 7).
Liquidity and Capital Resources
Consolidated working capital was $1.70 billion at July 3, 1999, compared
with $2.16 billion at January 2, 1999. Included in working capital were cash,
cash equivalents, and short-term available-for-sale investments of $1.07 billion
at July 3, 1999, compared with $1.55 billion at January 2, 1999. In addition,
the Company had $97.4 million of long-term available-for-sale investments at
July 3, 1999, compared with $95.5 million at January 2, 1999. Of the total $1.17
billion of cash, cash equivalents, and short- and long-term available-for-sale
investments at July 3, 1999, $1.09 billion was held by the Company's
majority-owned subsidiaries, and the balance was held by the Company and its
wholly owned subsidiaries.
Cash provided by operating activities was $90.1 million during the first
six months of 1999. Other current liabilities decreased by $52.9 million,
primarily due to a reduction in accrued taxes as a result of a tax benefit
recorded on the Company's pretax loss in 1999, as well as the timing of tax
payments. Cash of $11.8 million was used to fund
27
<PAGE>
Liquidity and Capital Resources (continued)
an increase in inventories, principally relating to analytical products at
Thermo Instrument due to the build-up of inventory in preparation for new
product releases and the timing of shipments. In addition, cash of $7.0 million
was used to fund an increase in accounts receivable, principally at Thermo
Ecotek due to increased activity at its natural gas business and at Thermo Power
due to the timing of shipments. These increases in accounts receivable were
offset by a reduction at Thermo Instrument primarily as a result of lower
revenues from analytical products in the second quarter of 1999 compared with
the fourth quarter of 1998.
During the first six months of 1999, the Company's primary investing
activities, excluding available-for-sale investments activity, included
acquisitions and the purchase of property, plant, and equipment. The Company
expended $345.2 million, net of cash acquired, for acquisitions and expended
$64.2 million for purchases of property, plant, and equipment. In addition,
Thermedics acquired all of the outstanding shares of Thermo Voltek common stock
that Thermedics and the Company did not already own, in completion of its merger
agreement, for $20.5 million of cash.
The Company's financing activities used $167.0 million of cash during the
first six months of 1999. During the first six months of 1999, the Company
expended $10.5 million to purchase shares of its common stock and the Company
and certain of its majority-owned subsidiaries expended $129.9 million to
purchase shares of common stock and debentures of certain of the Company's
majority-owned subsidiaries. These purchases were made pursuant to
authorizations by the Company's and certain majority-owned subsidiaries' Boards
of Directors. As of July 3, 1999, $111.9 million remained under the Company's
authorization, and $36.9 million remained under authorizations of the Company's
majority-owned subsidiaries. In addition, the Company used $17.1 million of cash
for the redemption of redeemable subsidiary common stock.
The Company has, from time to time, sold put options for shares of its
common stock to an institutional counterparty. As of July 3, 1999, the Company
had a maximum potential obligation under such arrangements to purchase 5,701,000
shares of its common stock for an aggregate of $83.0 million. The put options
are exercisable only at maturity, expire between November 1999 and May 2000, and
have a weighted average exercise price per share of $14.56. The Company has the
right to settle the put options by physical settlement of the options or by net
share settlement using shares of the Company's common stock.
In August 1999, Thermo Instrument called for redemption on September 3,
1999, all of the outstanding $14.5 million principal amount of its 3 3/4% senior
convertible debentures due 2000. The value of the securities into which the
debentures are convertible exceeded the redemption amount as of the notice date
of the redemption.
In connection with certain restructuring actions undertaken by the Company
and its subsidiaries during 1999, the Company expects to incur cash expenditures
of approximately $35 million during the remainder of 1999 and $53 million during
2000. The Company believes that the expected proceeds from businesses to be sold
in connection with certain restructuring actions will exceed the aggregate
estimated cash expenditures for restructuring actions and planned repurchases of
subsidiary common stock in connection with the Company's proposed reorganization
plan (Notes 7 and 8).
The Company has no material commitments for purchases of property, plant,
and equipment and expects that for the remainder of 1999 such expenditures will
approximate the current level of expenditures. As of August 12, 1999, the
Company's majority-owned subsidiaries acquired new businesses since July 3,
1999, for aggregate cash consideration of $55 million.
28
<PAGE>
Year 2000
The following information constitutes a "Year 2000 Readiness Disclosure"
under the Year 2000 Information and Readiness Disclosure Act. The Company
continues to assess the potential impact of the year 2000 date recognition issue
on the Company's internal business systems, products, and operations. The
Company's year 2000 initiatives include (i) testing and upgrading significant
information technology systems and facilities; (ii) testing and developing
upgrades, if necessary, for the Company's current products and certain
discontinued products; (iii) assessing the year 2000 readiness of its key
suppliers and vendors; and (iv) developing contingency plans.
The Company's State of Readiness
The Company has implemented a compliance program to ensure that its
critical information technology systems and non-information technology systems
will be ready for the year 2000. The first phase of the program, testing and
evaluating the Company's critical information technology systems and
non-information technology systems for year 2000 compliance, has largely been
completed. During phase one, the Company tested and evaluated its significant
computer systems, software applications, and related equipment for year 2000
compliance. The Company also evaluated the potential year 2000 impact on its
critical non-information technology systems. The Company's efforts included
testing the year 2000 readiness of its manufacturing, utility, and
telecommunications systems at its critical facilities. The Company is currently
in phase two of its program, during which any material noncompliant information
technology systems or non-information technology systems that were identified
during phase one are prioritized and remediated. Based on its evaluations, the
Company does not believe that it is required to make any material upgrades or
modifications to its critical non-information technology systems. The Company is
currently upgrading or replacing its material noncompliant information
technology systems, and the majority of this process was complete as of July 3,
1999. The Company expects that all of its material information technology
systems and critical non-information technology systems will be year 2000
compliant by the end of October 1999.
The Company has also implemented a compliance program to test and evaluate
the year 2000 readiness of the material products that it currently manufactures
and sells. The Company believes that all of such material products are year 2000
compliant. However, as many of the Company's products are complex, interact with
or incorporate third-party products, and operate on computer systems that are
not under the Company's control, there can be no assurance that the Company has
identified all of the year 2000 problems with its current products. The Company
believes that certain of its older products, which it no longer manufactures or
sells, may not be year 2000 compliant. The Company is continuing to test and/or
evaluate such products. The Company is focusing its efforts on products that are
still under warranty, early in their expected life, subject to FDA
considerations related to the year 2000, and/or pose a safety risk. The Company
is offering upgrades and/or identifying potential solutions where reasonably
practicable.
The Company is in the process of identifying and assessing the year 2000
readiness of key suppliers and vendors that are believed to be significant to
the Company's business operations. As part of this effort, the Company has
developed and distributed questionnaires relating to year 2000 compliance to its
significant suppliers and vendors. To date, no significant supplier or vendor
has indicated that it believes its business operations will be materially
disrupted by the year 2000 issue. The Company has begun to follow up with
significant suppliers and vendors that have not responded to the Company's
questionnaires. The Company has completed the majority of its assessment of
third-party risk, and expects to be substantially completed by the end of
October 1999.
Contingency Plans
The Company is developing contingency plans that will allow its primary
business operations to continue despite disruptions due to year 2000 problems.
These plans may include identifying and securing other suppliers, increasing
inventories, and modifying production facilities and schedules. As the Company
continues to evaluate the year 2000 readiness of its business systems,
facilities, products, and significant suppliers and vendors, it will modify and
adjust its contingency plans as may be required. The Company expects to complete
its contingency plan by October 1999.
29
<PAGE>
Year 2000 (continued)
Estimated Costs to Address the Company's Year 2000 Issues
The Company had incurred expenses to third parties (external costs)
related to year 2000 issues of approximately $8.0 million as of July 3, 1999,
and the total external costs of year 2000 remediation are expected to be
approximately $14 million. Year 2000 costs are funded from working capital. All
internal costs and related external costs other than capital additions related
to year 2000 remediation have been and will continue to be expensed as incurred.
The Company does not track the internal costs incurred for its year 2000
compliance project. Such costs are principally the related payroll costs for its
information systems group.
Reasonably Likely Worst Case Scenario
At this point in time, the Company is not able to determine the most
reasonably likely worst case scenario to result from the year 2000 issue. One
possible worst case scenario would be that certain of the Company's material
suppliers or vendors experience business disruptions due to the year 2000 issue
and are unable to provide materials and services to the Company on time. The
Company's operations could be delayed or temporarily shut down, and it could be
unable to meet its obligations to customers in a timely fashion. The Company's
business, operations, and financial condition could be adversely affected in
amounts that cannot be reasonably estimated at this time. If the Company
believes that any of its key suppliers or vendors may not be year 2000
compliant, it will seek to identify and secure other suppliers or vendors as
part of its contingency plan.
Risks of the Company's Year 2000 Issues
While the Company is attempting to minimize any negative consequences
arising from the year 2000 issue, there can be no assurance that year 2000
problems will not have a material adverse impact on the Company's business,
operations, or financial condition. While the Company expects that upgrades to
its internal business systems will be completed in a timely fashion, there can
be no assurance that the Company will not encounter unexpected costs or delays.
Despite its efforts to ensure that its material current products are year 2000
compliant, the Company may see an increase in warranty and other claims,
especially those related to Company products that incorporate, or operate using,
third-party software or hardware. In addition, certain of the Company's older
products, which it no longer manufactures or sells, may not be year 2000
compliant, which may expose the Company to claims. As described above, if any of
the Company's significant suppliers or vendors experience business disruptions
due to year 2000 issues, there may also be a material adverse effect on the
Company. If any countries in which the Company operates experience significant
year 2000 disruption, the Company could be materially adversely affected. There
is expected to be a significant amount of litigation relating to the year 2000
issue, and there can be no assurance that the Company will not incur material
costs in defending or bringing lawsuits. In addition, if any year 2000 issues
are identified, there can be no assurance that the Company will be able to
retain qualified personnel to remedy such issues. Any unexpected costs or delays
arising from the year 2000 issue could have a significant adverse impact on the
Company's business, operations, and financial condition in amounts that cannot
be reasonably estimated at this time.
Item 3 - Quantitative and Qualitative Disclosures About Market Risk
The Company's exposure to market risk from changes in interest rates,
foreign currency exchange rates, and equity prices has not changed materially
from its exposure at year-end 1998.
30
<PAGE>
PART II - OTHER INFORMATION
Item 4 - Submission of Matters to a Vote of Security Holders
On May 27, 1999, at the Annual Meeting of Shareholders, the shareholders
reelected a class of four incumbent directors to a three-year term expiring in
2002. The directors reelected at the meeting were: Mr. John N. Hatsopoulos, Mr.
Robert A. McCabe, Ms. Hutham S. Olayan, and Dr. Richard F. Syron. Mr.
Hatsopoulos received 136,729,207 shares voted in favor of his election and
5,043,582 shares voted against; Mr. McCabe received 138,146,885 shares voted in
favor of his election and 3,625,904 shares voted against. Ms. Olayan received
138,123,920 shares voted in favor of her election and 3,648,869 shares voted
against. Dr. Syron received 140,113,097 shares voted in favor of his election
and 1,659,692 shares voted against. No abstentions or broker nonvotes were
recorded on the election of directors.
At the Annual Meeting, the shareholders also approved a proposal to amend
and restate the Corporation's Certificate of Incorporation as follows:
117,177,490 shares voted in favor of the proposal, 1,739,032 shares voted
against, 563,640 shares abstained, and 22,292,627 broker nonvotes were recorded
on the proposal.
A shareholder proposal to endorse the CERES Principles was defeated by the
shareholders at the Annual Meeting as follows: 13,014,191 shares voted in favor
of the proposal, 102,791,378 shares voted against, 3,674,593 shares abstained,
and 22,292,627 broker nonvotes were recorded on the proposal.
A shareholder proposal to endorse an amendment to the Corporation's
Certificate of Incorporation such that the chief executive officer of the
Corporation shall always be a direct lineal descendent of the founder of the
Corporation was defeated by the shareholders at the Annual Meeting as follows:
10,692,095 shares voted in favor of the proposal, 107,859,558 shares voted
against, 928,511 shares abstained, and 22,292,625 broker nonvotes were recorded
on the proposal.
Item 6 - Exhibits and Reports on Form 8-K
(a) Exhibits
See Exhibit Index on page immediately preceding exhibits.
(b) Reports on Form 8-K
On May 25, 1999, the Company filed a Current Report on Form 8-K for events
occurring on May 24, 1999, with respect to amendments to its previously
announced corporate reorganization, restructuring and other charges totaling
approximately $450 million, and the appointment of Samuel W. Bodman to the
Company's Board of Directors.
31
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized as of the 12th day of August 1999.
THERMO ELECTRON CORPORATION
/s/ Paul F. Kelleher
Paul F. Kelleher
Senior Vice President, Finance and
Administration
/s/ Theo Melas-Kyriazi
Theo Melas-Kyriazi
Chief Financial Officer and Vice President
32
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit
3 Amended and Restated ByLaws of the Registrant.
10.1 Amended and Restated Deferred Compensation Plan for Directors of the Registrant.
10.2 Amended and Restated Directors' Stock Option Plan of the Registrant.
10.3 Amended and Restated Nonqualified Stock Option Plan of the Registrant.
10.4 Amended and Restated Equity Incentive Plan of the Registrant.
10.5 Amended and Restated Thermo Electron Corporation - Thermedics Inc. Nonqualified Stock
Option Plan.
10.6 Amended and Restated Thermo Electron Corporation - Thermo Instrument Systems Inc.
Nonqualified Stock Option Plan.
10.7 Amended and Restated Thermo Electron Corporation - Thermo TerraTech Inc. Nonqualified
Stock Option Plan.
10.8 Amended and Restated Thermo Electron Corporation - Thermo Power Corporation Nonqualified
Stock Option Plan.
10.9 Amended and Restated Thermo Electron Corporation - Thermo Cardiosystems Inc. Nonqualified
Stock Option Plan.
10.10 Amended and Restated Thermo Electron Corporation - Thermo Ecotek Corporation Nonqualified
Stock Option Plan.
10.11 Amended and Restated Thermo Electron - ThermoTrex Corporation Nonqualified Stock Option
Plan.
10.12 Amended and Restated Thermo Electron Corporation - Thermo Fibertek Inc. Nonqualified
Stock Option Plan.
10.13 Amended and Restated Thermo Electron Corporation - Thermo Voltek Corp. Nonqualified Stock
Option Plan.
10.14 Amended and Restated Thermo Electron Corporation - Thermo BioAnalysis Corporation
Nonqualified Stock Option Plan.
10.15 Amended and Restated Thermo Electron Corporation - ThermoLyte Corporation Nonqualified
Stock Option Plan.
10.16 Amended and Restated Thermo Electron Corporation - ThermoRetec Corporation Nonqualified
Stock Option Plan.
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit
10.17 Amended and Restated Thermo Electron Corporation - ThermoSpectra Corporation Nonqualified
Stock Option Plan.
10.18 Amended and Restated Thermo Electron Corporation - ThermoLase Corporation Nonqualified
Stock Option Plan.
10.19 Amended and Restated Thermo Electron Corporation - ThermoQuest Corporation Nonqualified
Stock Option Plan.
10.20 Amended and Restated Thermo Electron Corporation - Thermo Optek Corporation Nonqualified
Stock Option Plan.
10.21 Amended and Restated Thermo Electron Corporation - Thermo Sentron Inc. Nonqualified Stock
Option Plan.
10.22 Amended and Restated Thermo Electron Corporation - Trex Medical Corporation Nonqualified
Stock Option Plan.
10.23 Amended and Restated Thermo Electron Corporation - Thermo Fibergen Inc. Nonqualified
Stock Option Plan.
10.24 Amended and Restated Thermo Electron Corporation - Thermedics Detection Inc. Nonqualified
Stock Option Plan.
10.25 Amended and Restated Thermo Electron Corporation - Metrika Systems Corporation
Nonqualified Stock Option Plan.
10.26 Amended and Restated Thermo Electron - Thermo Vision Corporation Nonqualified Stock
Option Plan.
10.27 Amended and Restated Thermo Electron Corporation - ONIX Systems Inc. Nonqualified Stock
Option Plan.
10.28 Amended and Restated Thermo Electron Corporation - The Randers Killam Group Inc.
Nonqualified Stock Option Plan.
10.29 Amended and Restated Thermo Electron Corporation - Trex Communications Corporation
Nonqualified Stock Option Plan.
10.30 Amended and Restated Thermo Electron Corporation - Thermo Trilogy Corporation
Nonqualified Stock Option Plan.
10.31 1997 Spectra-Physics Lasers, Inc. Stock Option Plan (filed as Exhibit 10.6 of Amendment
No. 1 to Spectra-Physics, Lasers Inc.'s Registration Statement on Form S-1 [File No.
333-38329] and is incorporated herein by reference).
27 Financial Data Schedule.
</TABLE>
As amended and effective as of July 22, 1999
THERMO ELECTRON CORPORATION
BY-LAWS
TABLE OF CONTENTS
Title Page
Article I - Stockholders 1
Section 1. Annual Meeting 1
Section 2. Special Meetings 1
Section 3. Notice of Meetings 1
Section 4. Quorum; Adjournments 1
Section 5. Voting; Proxies 2
Section 6 Inspectors of Elections 2
Section 7. Presiding Officer and Secretary 2
Section 8. List of Stockholders 3
Section 9. Advance Notice of Stockholder Nominations
and Proposals 3
Section 10. Action Without Meeting 5
Article II- Directors 6
Section 1. General Powers 6
Section 2. Number and Qualification 6
Section 3. Classes of Directors 6
Section 4. Terms of Office 6
Section 5. Vacancies 6
Section 6. Resignations 7
Section 7. Meetings 7
Section 8. Notice of Meetings 7
Section 9. Quorum 7
Section 10. Action at Meeting 7
Section 11. Action by Consent 7
Section 12. Meetings by Telephone Conference Call 8
Section 13. Compensation of Directors 8
Section 14. Committees 8
(i)
<PAGE>
Title Page
Article III - Officers 8
Section 1. General Provisions; Qualification 8
Section 2. Election 9
Section 3. Tenure 9
Section 4. Resignation and Removal 9
Section 5. Vacancies 9
Section 6. The Chief Executive Officer 9
Section 7. The President 9
Section 8. Vice Presidents 9
Section 9. Chief Financial Officer 9
Section 10. General Counsel 10
Section 11. The Treasurer 10
Section 12. The Secretary 10
Section 13. Assistant Treasurers 10
Section 14. Assistant Secretaries 10
Section 15. Other Officers 10
Section 16. Delegation of Duties 10
Section 17. Salaries 11
Article IV - Capital Stock 11
Section 1. Certificates for Shares 11
Section 2. Transfer of Shares of Stock 11
Section 3. Lost, Stolen or Destroyed Certificates 11
Section 4. Record Date 11
Section 5. Regulations 12
Article V - General Provisions 12
Section 1. Fiscal Year 12
Section 2. Corporate Seal 12
Section 3. Waiver of Notice 12
Section 4. Voting of Securities 13
Section 5. Evidence of Authority 13
Section 6. Certificate of Incorporation 13
Section 7. Transactions with Interested Parties 13
Section 8. Severability 14
Article VI - Amendments 14
Section 1. By the Board of Directors 14
Section 2. By the Stockholders 14
Section 3. Certain Provisions 14
(ii)
<PAGE>
THERMO ELECTRON CORPORATION
BY-LAWS
ARTICLE I - STOCKHOLDERS
Section 1. Annual Meeting. The annual meeting of the stockholders, for the
election of directors to succeed those whose terms expire and for the
transaction of such other business as may properly come before the meeting,
shall be held at such place, on such date, and at such time as the Board of
Directors may each year fix.
Section 2. Special Meetings. Special meetings of stockholders may be
called only by the Board of Directors, the Chairman of the Board of Directors,
or the Chief Executive Officer. Special meetings may be held at such place, on
such date, and at such time as the person(s) calling the meeting may specify.
Business transacted at any special meeting of stockholders shall be limited to
matters relating to the purpose or purposes stated in the notice of meeting. The
Board of Directors may postpone or reschedule any previously scheduled special
meeting.
Section 3. Notice of Meetings. Written notice of the place, date, and time
of all meetings of the stockholders shall be given, not less than ten (10) nor
more than sixty (60) days before the date on which the meeting is to be held, to
each stockholder entitled to vote at such meeting, except as otherwise required
by the Delaware General Corporation Law (meaning, here and hereinafter, the
General Corporation Law of the State of Delaware, as amended and in effect from
time to time, the "Delaware General Corporation Law").
Section 4. Quorum; Adjournments. At any meeting of the stockholders, the
holders of a majority of all of the shares of the stock entitled to vote at the
meeting, present in person or by proxy, shall constitute a quorum for all
purposes, unless or except to the extent that the presence of a larger number
may be required by the Certificate of Incorporation or the Delaware General
Corporation Law. Where a separate vote by a class or classes or series is
required, a majority of the shares of such class or classes or series present in
person or represented by proxy shall constitute a quorum entitled to take action
with respect to that vote on that matter.
If a quorum shall fail to attend any meeting, the presiding officer may
adjourn the meeting to another place, date, or time. When a meeting is adjourned
to another place, date or time, written notice need not be given of the
adjourned meeting if the place, date and time thereof are announced at the
meeting at which the adjournment is taken; provided, however, that if the date
of any adjourned meeting is more than thirty (30) days after the date for which
the meeting was originally noticed, or if a new record date is fixed for the
adjourned meeting, written notice of the place, date, and time of the adjourned
meeting shall be given in conformity herewith. At any adjourned meeting, any
business may be transacted that could have been transacted at the original
meeting.
<PAGE>
2
Section 5. Voting; Proxies. Each stockholder shall have one vote for each
share of stock entitled to vote held of record by such stockholder unless
otherwise provided by the Delaware General Corporation Law or the Certificate of
Incorporation. Each stockholder of record entitled to vote at a meeting of
stockholders, or to express consent or dissent to corporate action in writing
without a meeting, may vote or express such consent or dissent in person or may
authorize another person or persons to vote or act for the stockholder by
written proxy executed by the stockholder or the stockholder's authorized agent
and delivered to the Secretary of the Corporation. No such proxy shall be voted
or acted upon after three years from the date of its execution, unless the proxy
expressly provides for a longer period.
When a quorum is present at any meeting, the affirmative vote of holders
of a majority of the stock present or represented and entitled to vote and
voting affirmatively or negatively on a matter (or if there are two or more
classes or series of stock entitled to vote as separate classes, then in the
case of each such class or series, the holders of a majority of the stock of
that class present or represented and voting affirmatively or negatively on a
matter) shall constitute stockholder action on any matter to be voted upon by
the stockholders at such meeting, except when a different vote is required by
the Delaware General Corporation Law, the Certificate of Incorporation or these
By-laws. Except as may be otherwise required by the Certificate of
Incorporation, any election by stockholders of directors shall be determined by
a plurality of the votes cast by the stockholders entitled to vote at the
election.
Section 6. Inspectors of Elections. The Corporation may, and to the extent
required by the Delaware General Corporation Law, shall, in advance of any
meeting of the stockholders, appoint one or more inspectors to act at the
meeting and make a written report thereof and perform the other duties of
inspectors at meetings of stockholders as set forth in the Delaware General
Corporation Law. The Corporation may designate one or more persons as alternate
inspectors to replace any inspector who fails to act. If no inspector or
alternate is able to act at a meeting of stockholders, the person presiding at
the meeting may, and to the extent required by the Certificate of Incorporation
or the Delaware General Corporation Law, shall, appoint one or more persons to
act at the meeting. Each inspector, before entering the discharge of the
inspector's duties, shall take and sign an oath faithfully to execute the duties
of inspector with strict impartiality and according to the best of the
inspector's ability.
Section 7. Presiding Officer and Secretary. The Chairman of the Board, or
in the Chairman's absence, the Chief Executive Officer, or in the Chief
Executive Officer's absence, the President, or in the President's absence, the
Chief Financial Officer, in such order, shall call meetings of the stockholders
to order, and shall act as presiding officer of such meeting. The presiding
officer shall determine the order of business and the procedure at meetings,
including such regulation of the manner of voting and the conduct of discussion
as seem to the presiding officer in order. The presiding officer shall have the
power to adjourn meetings to another place, date, and time. The date and time of
the opening and closing of the polls for each matter upon which the stockholders
will vote at a meeting shall be announced at the meeting. The Secretary of the
Corporation, or in the Secretary's absence, any Assistant Secretary, shall act
as the secretary at all meetings of the stockholders, but in the absence of the
Secretary and any Assistant Secretary, the presiding officer may appoint any
person to act as secretary of the meeting.
2
<PAGE>
Section 8. List of Stockholders. The Secretary shall prepare, at least 10
days before every meeting of stockholders, a complete list of the stockholders
entitled to vote at the meeting, arranged in alphabetical order, and showing the
address of each stockholder and the number of shares registered in the name of
each stockholder. Such list shall be open to the examination of any stockholder,
for any purpose germane to the meeting, during ordinary business hours, for a
period of at least 10 days prior to the meeting, at a place within the city
where the meeting is to be held. The list shall also be produced and kept at the
time and place of the meeting during the whole time of the meeting, and may be
inspected by any stockholder who is present.
Section 9. Advance Notice of Stockholder Nominations and Proposals.
1. Nominations of persons for election to the Board of Directors and the
proposal of business to be transacted by the stockholders may be made at an
annual meeting of stockholders (a) pursuant to the Corporation's notice with
respect to such meeting, (b) by or at the direction of the Board or (c) by any
stockholder of record of the Corporation who was a stockholder of record at the
time of the giving of the notice provided for in the following paragraph, who is
entitled to vote at the meeting and who has complied with the notice procedures
set forth in this Section 9.
2. For nominations or other business to be properly brought before an
annual meeting by a stockholder pursuant to clause (c) of the foregoing
paragraph, (1) the stockholder must have given timely notice thereof in writing
to the Secretary of the Corporation, (2) such business must be a proper matter
for stockholder action under the Delaware General Corporation Law, (3) if the
stockholder, or the beneficial owner on whose behalf any such proposal or
nomination is made, has provided the Corporation with a Solicitation Notice, as
that term is defined in subclause (c)(iii) of this paragraph, such stockholder
or beneficial owner must, in the case of a proposal, have delivered a proxy
statement and form of proxy to holders of at least the percentage of the
Corporation's voting shares required under the Delaware General Corporation Law
to carry any such proposal, or, in the case of a nomination or nominations, have
delivered a proxy statement and form of proxy to holders of a percentage of the
Corporation's voting shares reasonably believed by such stockholder or
beneficial holder to be sufficient to elect the nominee or nominees proposed to
be nominated by such stockholder, and must, in either case, have included in
such materials the Solicitation Notice, and (4) if no Solicitation Notice
relating thereto has been timely provided pursuant to this Section 9, the
stockholder or beneficial owner proposing such business or nomination must not
have solicited a number of proxies sufficient to have required the delivery of
such a Solicitation Notice under this Section 9. To be timely, a stockholder's
notice shall be delivered to the Secretary at the principal executive offices of
the Corporation not less than 60 or more than 75 days prior to the first
anniversary (the "Anniversary") of the date on which the Corporation first
mailed its proxy materials for the preceding year's annual meeting of
stockholders; provided, however, that if the date of the annual meeting is
advanced more than 30 days prior to or delayed by more than 30 days after the
anniversary of the preceding year's annual meeting, notice by the stockholder to
be timely must be so delivered not later than the close of business on the later
of (i) the 90th day prior to such annual meeting or (ii) the 10th day following
the day on which public announcement of the date of such meeting is first made.
Such stockholder's notice shall set forth (a) as to each person whom the
3
<PAGE>
stockholder proposes to nominate for election or reelection as a director all
information relating to such person as would be required to be disclosed in
solicitations of proxies for the election of such nominees as directors pursuant
to Regulation 14A under the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and such person's written consent to serve as a director if
elected; (b) as to any other business that the stockholder proposes to bring
before the meeting, a brief description of such business, the reasons for
conducting such business at the meeting and any material interest in such
business of such stockholder and the beneficial owner, if any, on whose behalf
the nomination or proposal is made; (c) as to the stockholder giving the notice
and the beneficial owner, if any, on whose behalf the nomination is made (i) the
name and address of such stockholder, as they appear on the Corporation's books,
and of such beneficial owner, (ii) the class and number of shares of the
Corporation that are owned beneficially and of record by such stockholder and
such beneficial owner, and (iii) whether either such stockholder or beneficial
owner intends to deliver a proxy statement and form of proxy to holders of, in
the case of a proposal, at least the percentage of the Corporation's voting
shares required under the Delaware General Corporation Law to carry the proposal
or, in the case of a nomination or nominations, a sufficient number of holders
of the Corporation's voting shares to elect such nominee or nominees (an
affirmative statement of such intent, a "Solicitation Notice").
3. Notwithstanding anything in the second sentence of the second paragraph
of this Section 9 to the contrary, in the event that the number of directors to
be elected to the Board is increased and there is no public announcement naming
all of the nominees for director or specifying the size of the increased Board
made by the Corporation at least 70 days prior to the Anniversary, a
stockholder's notice required by this By-law shall also be considered timely,
but only with respect to nominees for any new positions created by such
increase, if it shall be delivered to the Secretary at the principal executive
offices of the Corporation not later than the close of business on the 10th day
following the day on which such public announcement is first made by the
Corporation.
4. Only persons nominated in accordance with the procedures set forth in
this Section 9 shall be eligible to serve as directors and only such business
shall be conducted at an annual meeting of stockholders as shall have been
brought before the meeting in accordance with the procedures set forth in this
Section 9. The presiding officer of the meeting shall have the power and the
duty to determine whether a nomination or any business proposed to be brought
before the meeting has been made in accordance with the procedures set forth in
these By-laws and, if any proposed nomination or business is not in compliance
with these By-laws, to declare that such defective proposed business or
nomination shall not be presented for stockholder action at the meeting and
shall be disregarded.
5. Only such business shall be conducted at a special meeting of
stockholders as shall have been brought before the meeting pursuant to the
Corporation's notice of meeting. Nominations of persons for election to the
Board may be made at a special meeting of stockholders at which directors are to
be elected pursuant to the Corporation's notice of meeting (a) by or at the
direction of the Board or (b) by any stockholder of record of the Corporation
who is a stockholder of record at the time of giving of notice provided for in
this paragraph, who shall be entitled to vote at the meeting and who complies
with the procedures set forth in this Section 9, including, without limitation,
4
<PAGE>
the procedures regarding Solicitation Notices. Nominations by stockholders of
persons for election to the Board may be made at such a special meeting of
stockholders if the stockholder's notice required by the second paragraph of
this Section 9 shall be delivered to the Secretary at the principal executive
offices of the Corporation not later than the close of business on the later of
the 90th day prior to such special meeting or the 10th day following the day on
which public announcement is first made of the date of the special meeting and
of the nominees proposed by the Board to be elected at such meeting.
For purposes of this Section 9, "public announcement" shall mean
disclosure in a press release reported by the Dow Jones News Service, Associated
Press or a comparable national news service or in a document publicly filed by
the Corporation with the Securities and Exchange Commission pursuant to Section
13, 14 or 15(d) of the Exchange Act.
Notwithstanding the foregoing provisions of this Section 9, a stockholder
shall also comply with all applicable requirements of the Exchange Act and the
rules and regulations thereunder with respect to matters set forth in this
Section 9. Nothing in this Section 9 shall be deemed to affect any rights of
stockholders to request inclusion of proposals in the Corporation's proxy
statement pursuant to Rule 14a-8 under the Exchange Act.
Section 10. Action Without Meeting. Unless otherwise provided in the
Certificate of Incorporation, any action required or permitted to be taken by
stockholders for or in connection with any corporate action may be taken without
a meeting, without prior notice and without a vote, if a consent or consents in
writing, setting forth the action so taken, shall be signed by the holders of
outstanding stock having not less than the minimum number of votes that would be
necessary to authorize or take such action at a meeting at which all shares
entitled to vote thereon were present and voted and shall be delivered to the
Corporation by delivery to its registered office in Delaware, its principal
place of business, or an officer or agent of the Corporation having custody of
the book in which proceedings of meetings of stockholders are recorded.
Deliveries made to the Corporation's registered office in Delaware shall be by
hand or certified or registered mail, return receipt requested. Each such
written consent shall bear the date of signature of each stockholder who signs
the consent. No written consent shall be effective to take the corporate action
referred to therein unless written consents signed by a number of stockholders
sufficient to take such action are delivered to the Corporation in the manner
specified in this paragraph within sixty (60) days of the earliest dated consent
so delivered.
If action is taken by consent of stockholders and in accordance with the
foregoing, there shall be filed with the records of the meetings of stockholders
the writing or writings comprising such consent.
If action is taken by less than unanimous consent of stockholders, prompt
notice of the taking of such action without a meeting shall be given to those
who have not consented in writing and a certificate signed and attested to by
the Secretary of the Corporation that such notice was given shall be filed with
the records of the meetings of stockholders.
5
<PAGE>
In the event that the action consented to is such as would have required
the filing of a certificate under any provision of the Delaware General
Corporation Law, if such action had been voted upon by the stockholders at a
meeting thereof, the certificate filed under such provision shall state, in lieu
of any statement required by such provision concerning a vote of stockholders,
that written consent has been given under Section 228 of the Delaware General
Corporation Law.
ARTICLE II - DIRECTORS
Section 1. General Powers. The business and affairs of the Corporation
shall be managed by or under the direction of a Board of Directors, who may
exercise all of the powers of the Corporation except as otherwise provided by
the Certificate of Incorporation or the Delaware General Corporation Law. In the
event of a vacancy in the Board of Directors, the remaining directors, except as
otherwise provided by the Certificate of Incorporation or the Delaware General
Corporation Law, may exercise the powers of the full Board of Directors until
the vacancy is filled. The Board of Directors may appoint a Chairman of the
Board. The Chairman of the Board shall preside at all meetings of the Board of
Directors and shall perform such duties and possess such powers as are assigned
to the Chairman by the Board of Directors.
Section 2. Number and Qualification. Except as otherwise required by the
Certificate of Incorporation, the number of directors that shall constitute the
whole Board of Directors shall be determined by resolution of the Board of
Directors, but in no event shall be less than three (3). The number of directors
may be increased at any time by resolution of the Board of Directors. The number
of directors may be decreased at any time and from time to time by a majority of
the directors then in office, but only to eliminate vacancies existing by reason
of the death, resignation, removal or expiration of the term of one or more
directors.
Section 3. Classes of Directors. The Board of Directors shall be divided
into three classes as nearly as equal in number as possible. If the number of
directors is changed, any increase or decrease shall be apportioned among the
classes so as to maintain the number of directors in each class as nearly as
equal as possible. Such classes shall consist of one class of directors who
shall be elected for a three-year term expiring at the annual meeting of
stockholders held in 1986; a second class of directors who shall be elected for
a three-year term expiring at the annual meeting of stockholders held in 1987;
and a third class of directors who shall be elected for a three-year term
expiring at the annual meeting of stockholders held in 1988. At each annual
meeting of stockholders beginning in 1986, the successors of the class of
directors whose term expires at that annual meeting shall be elected for a
three-year term.
Section 4. Terms of Office. Subject to Section 5 of this Article II, each
director shall serve for a term ending on the date of the third annual meeting
following the annual meeting at which such director was elected; provided that
the term of each director shall be subject to the election and qualification of
such director's successor and to such director's earlier death, resignation or
removal.
6
<PAGE>
Section 5. Vacancies. Except as otherwise required by the Certificate of
Incorporation or the Delaware General Corporation Law, any vacancy in the Board
of Directors, however occurring, or any newly-created directorship resulting
from an enlargement of the size of the Board of Directors, shall be filled only
by vote of a majority of the directors then in office, even if less than a
quorum, or by the sole remaining director and not by the stockholders. A
director elected to fill a vacancy shall be elected for the unexpired term of
such director's predecessor in office, and a director chosen to fill a newly
created directorship shall hold office until the next election of the class for
which such director shall have been chosen, subject in each case to the election
and qualification of the director's successor and to the director's earlier
death, resignation or removal.
Section 6. Resignations. Any director may resign by delivering a written
resignation to the Corporation at its principal office or to the Chief Executive
Officer or Secretary. Such resignation shall be effective upon receipt unless it
is specified to be effective at some other time or upon the happening of some
other event.
Section 7. Meetings. Regular meetings of the Board of Directors may be
held without notice at such time and place, either within or without the State
of Delaware, as shall be determined from time to time by the Board of Directors.
A regular meeting of the Board of Directors may be held without notice
immediately after and at the same place as the annual meeting of stockholders.
Special meetings of the Board of Directors may be called by the Chairman of the
Board, the Chief Executive Officer, a majority of the total number of the whole
Board of Directors, or by one director in the event that there is only a single
director in office and may held at any time and place, within or without the
State of Delaware, as specified by the person(s) calling the meeting.
Section 8. Notice of Meetings. No notice of the annual or other regular
meetings of the Board of Directors need be given. Notice of any special meeting
of directors shall be given to each director by the Secretary. Notice to each
director shall be duly given by mailing the same not later than the second
business day before the meeting, or by giving notice in person, by fax, by
telephone, or by any other electronic means not later than four hours before the
meeting. No notice of a meeting need be given if all directors are present in
person. Any business may be transacted at any meeting of the Board of Directors,
whether or not specified in a notice of the meeting.
Section 9. Quorum. A majority of the total number of the whole Board of
Directors shall constitute a quorum at all meetings of the Board of Directors.
In the absence of a quorum at any such meeting, a majority of the directors
present may adjourn the meeting from time to time to a different date, place, or
time without further notice (or waiver of notice) other than announcement at the
meeting, until a quorum shall be present.
Section 10. Action at Meeting. At any meeting of the Board of Directors at
which a quorum is present, the vote of a majority of the directors present shall
be sufficient to take any action, unless a different vote is specified by the
Delaware General Corporation Law, the Certificate of Incorporation or these
By-laws.
7
<PAGE>
Section 11. Action by Consent. Any action required or permitted to be
taken at any meeting of the Board of Directors or of any committee of the Board
of Directors may be taken without a meeting, if all members of the Board of
Directors or committee, as the case may be, consent to the action in writing,
and the written consents are filed with the minutes of proceedings of the Board
of Directors or committee.
Section 12. Meetings by Telephone Conference Call. Directors or any
members of any committee designated by the directors may participate in a
meeting of the Board of Directors or such committee by means of conference
telephone or similar communications equipment by means of which all persons
participating in the meeting can hear each other, and participation by such
means shall constitute presence in person at such meeting.
Section 13. Compensation of Directors. Directors may be paid such
compensation for their services and such reimbursement for expenses of
attendance at meetings of the Board of Directors or committees of the Board of
Directors as the Board of Directors or any committee to which the Board has
delegated responsibility for establishing director compensation may from time to
time determine. No such payment shall preclude any director from serving the
Corporation or any of its parent, subsidiary, or affiliate corporations in any
other capacity and receiving compensation for such service.
Section 14. Committees. The Board of Directors may designate one or more
committees, each committee to consist of one or more of the directors of the
Corporation. The Board of Directors may designate one or more directors as
alternate members of any committee, who may replace any absent or disqualified
member at any meeting of the committee. In the absence or disqualification of a
member of a committee, the member or members of the committee present at any
meeting and not disqualified from voting, whether or not the member or members
constitute a quorum, may unanimously appoint another member of the Board of
Directors to act at the meeting in the place of any such absent or disqualified
member. Any such committee, to the extent provided in the resolution of the
Board of Directors and subject to the provisions of the Delaware General
Corporation Law, shall have and may exercise all the powers and authority of the
Board of Directors in the management of the business and affairs of the
Corporation and may authorize the seal of the Corporation to be affixed to all
papers that may require it. Each such committee shall keep minutes and make such
reports as the Board of Directors may from time to time request. Except as the
Board of Directors may otherwise determine, any committee may make rules for the
conduct of its business, but unless otherwise provided by the directors or in
such rules, its business shall be conducted as nearly as possible in the same
manner as is provided in these By-laws for the Board of Directors. A majority of
the members of a committee shall constitute a quorum unless the committee
consist of one or two members, in which event, one member shall constitute a
quorum. All matters shall be determined by a majority vote of the committee
members present.
ARTICLE III - OFFICERS
Section 1. General Provisions; Qualification. The officers of the
Corporation shall be a Chief Executive Officer, a President, a Chief Financial
Officer, a General Counsel, a Treasurer and a Secretary, and may include one or
more Vice Presidents, one or more Assistant Treasurers and one or more Assistant
Secretaries and such other officers as the Board of Directors may deem
appropriate. Any two or more offices may be held by the same person.
8
<PAGE>
Section 2. Election. The Chief Executive Officer, the President, the Chief
Financial Officer, the General Counsel, the Treasurer and Secretary shall be
elected annually by the Board of Directors at its first meeting following the
annual meeting of stockholders. Other officers may be appointed by the Board of
Directors at such meeting or at any other meeting.
Section 3. Tenure. Except as otherwise provided by the Delaware General
Corporation Law, by the Certificate of Incorporation or by these By-laws, each
officer shall hold office until such officer's successor is elected and
qualified, unless a different term is specified in the vote choosing or
appointing such officer, or until such officer's earlier death, resignation or
removal.
Section 4. Resignation and Removal. Any officer may resign by delivering a
written resignation to the Corporation at its principal office or to the Chief
Executive Officer or the Secretary. Such resignation shall be effective upon
receipt unless it is specified to be effective at some other time or upon the
happening of some other event. Any officer may be removed at any time, with or
without cause by vote of the Board of Directors.
Section 5. Vacancies. The Board of Directors may at any time fill any
vacancy occurring in any office for any reason. Each such successor shall hold
office for the unexpired term of such successor's predecessor and until such
successor's successor is elected and qualified, or until such successor's
earlier death, resignation or removal.
Section 6. The Chief Executive Officer. The Chief Executive Officer shall
be the principal executive officer of the Corporation. Subject to the control of
the Board of Directors, the Chief Executive Officer shall have general charge of
the business and affairs of the Corporation. The Chief Executive Officer shall
employ and discharge employees and agents of the Corporation, except such as
shall hold their offices by appointment of the Board of Directors, but the Chief
Executive Officer may delegate these powers to other officers as to employees
under their immediate supervision. The Chief Executive Officer shall have such
other powers and perform such other duties as may be prescribed by the Board of
Directors.
Section 7. The President. The Board of Directors may appoint an officer of
the Corporation to serve as the President of the Corporation. The President
shall perform such of the duties of the Chief Executive Officer of the
Corporation on behalf of the Corporation as may be assigned to the President
from time to time by the Board of Directors or the Chief Executive Officer. In
the absence or inability of the Chief Executive Officer to act, the President
shall have and possess all of the powers and discharge all of the duties of the
Chief Executive Officer, subject to the control of the Board of Directors.
Section 8. Vice Presidents. Each Vice President shall have such powers and
perform such duties as the Board of Directors, the Chief Executive Officer, or
the President may from time to time prescribe.
9
<PAGE>
Section 9. Chief Financial Officer. The Board of Directors shall appoint
an officer to serve as the Chief Financial Officer of the Corporation. The Chief
Financial Officer shall be responsible for the Corporation's public financial
reporting obligations and shall have such further powers and duties as are
incident to the position of Chief Financial Officer, subject to the direction of
the Chief Executive Officer and the Board of Directors.
Section 10. General Counsel. The Board of Directors shall appoint an
officer to serve as the General Counsel of the Corporation. The General Counsel
shall be the chief legal officer of the Corporation and shall be responsible for
all legal affairs of the Corporation, and shall have such further powers and
duties as are incident to the position of General Counsel.
Section 11. The Treasurer. The Treasurer shall perform such duties and
shall have such powers as may from time to time be assigned to the Treasurer by
the Board of Directors or the Chief Executive Officer. In addition, subject to
the direction of the Board of Directors, the Treasurer shall perform such duties
and have such powers as are incident to the office of treasurer, including,
without limitation, the duty and power to keep and be responsible for all funds
and securities of the Corporation, to deposit funds of the Corporation in
depositories, to disburse such funds, to make proper accounts of such funds, and
to render statements of all such transactions and of the financial condition of
the Corporation. The Treasurer shall report directly to the Chief Executive
Officer.
Section 12. The Secretary. The Secretary shall keep the minutes of all
meetings of the Board of Directors and of the stockholders and shall attend to
the giving and serving of all notices of the Corporation. The Secretary shall
have custody of the seal of the Corporation and shall affix the seal to all
certificates of shares of stock of the Corporation and to such other papers or
documents as may be proper and, when the seal is so affixed, the Secretary shall
attest the same by the Secretary's signature wherever required. The Secretary
shall have charge of the stock certificate book, transfer book, and stock
ledger, and such other books and papers as the Board of Directors may direct.
The Secretary shall, in general, perform all the duties of secretary, subject to
the control of the Board of Directors.
Section 13. Assistant Treasurers. In the absence or inability of the
Treasurer to act, any Assistant Treasurer may perform all the duties and
exercise all of the powers of the Treasurer, subject to the control of the Board
of Directors. An Assistant Treasurer shall also perform such other duties as the
Board of Directors, the Chief Executive Officer, or the Treasurer may from time
to time prescribe.
Section 14. Assistant Secretaries. In the absence or inability of the
Secretary to act, any Assistant Secretary may perform all the duties and
exercise all the powers of the Secretary, subject to the control of the Board of
Directors. An Assistant Secretary shall also perform such other duties as the
Board of Directors, the Chief Executive Officer, or the Secretary may from time
to time prescribe.
Section 15. Other Officers. Other officers shall perform such duties
and have such powers as may from time to time be assigned to them by the
Board of Directors.
10
<PAGE>
Section 16. Delegation of Duties. In case of the absence of any officer of
the Corporation, or for any other reason that the Board of Directors may deem
sufficient, the Board of Directors may confer, for the time being, the powers or
duties, or any of them, of such officer upon any other officer, or upon any
director.
Section 17. Salaries. Officers of the Corporation shall be entitled
to such salaries, compensation, or reimbursement as shall be fixed or allowed
from time to time by the Board of Directors.
ARTICLE IV - CAPITAL STOCK
Section 1. Certificates for Shares. Each stockholder shall be entitled to
a certificate signed by, or in the name of the Corporation by, the Chairman of
the Board, the Chief Executive Officer, or the President or a Vice President,
and by the Secretary or an Assistant Secretary, or Treasurer or an Assistant
Treasurer, certifying the class and number of shares of record owned by such
stockholder. Any or all of the signatures may be a facsimile.
Section 2. Transfer of Shares of Stock. Transfers of stock shall be made
only upon the transfer books of the Corporation kept at an office of the
Corporation or by transfer agents designated to transfer shares of the stock of
the Corporation. Except where a certificate is issued in accordance with Section
3 of this Article IV of these By-laws, an outstanding certificate for the number
of shares involved shall be surrendered for cancellation before a new
certificate is issued therefor.
Section 3. Lost, Stolen or Destroyed Certificates. In the event of the
loss, theft or destruction of any certificate of stock, another may be issued in
its place pursuant to such regulations as the Board of Directors or transfer
agent may establish concerning proof of such loss, theft, or destruction and
concerning the giving of a satisfactory bond or bonds of indemnity.
Section 4. Record Date.
(a) In order that the Corporation may determine the stockholders entitled
to notice of or to vote at any meeting of stockholders, or to receive payment of
any dividend or other distribution or allotment of any rights or to exercise any
rights in respect of any change, conversion, or exchange of stock or for the
purpose of any other lawful action, the Board of Directors may, except as
otherwise required by the Delaware General Corporation Law, fix a record date,
which record date shall not precede the date on which the resolution fixing the
record date is adopted and which record date shall not be more than sixty (60)
nor less than ten (10) days before the date of any meeting of stockholders, nor
more than sixty (60) days prior to the time for such other action as
hereinbefore described; provided, however, that if no record date is fixed by
the Board of Directors, the record date for determining stockholders entitled to
notice of or to vote at a meeting of stockholders shall be at the close of
business on the day next preceding the day on which notice is given or, if
notice is waived, at the close of business on the day next preceding the day on
which the meeting is held, and, for determining stockholders entitled to receive
payment of any dividend or other distribution or allotment of rights or to
exercise any rights of change, conversion, or exchange of stock or for any other
purpose, the record date shall be at the close of business on the day on which
the Board of Directors adopts a resolution relating thereto. A determination of
stockholders of record entitled to notice of or to vote at a meeting of
stockholders shall apply to any adjournment of the meeting; provided, however,
that the Board of Directors may fix a new record date for the adjourned meeting.
11
<PAGE>
(b) In order that the Corporation may determine the stockholders entitled
to consent to corporate action in writing without a meeting, the Board of
Directors may fix a record date, which record date shall not precede the date
upon which the resolution fixing the record date is adopted by the Board of
Directors, and which date shall not be more than ten (10) days after the date
upon which the resolution fixing the record date is adopted by the Board of
Directors. Any stockholder of record seeking to have the stockholders authorize
or take corporate action by written consent shall, by written notice to the
Secretary of the Corporation, request the Board of Directors to fix a record
date. The Board of Directors shall promptly, but in all events within ten (10)
days after the date on which such a request is received by the Secretary, adopt
a resolution fixing the record date. If no record date has been fixed by the
Board of Directors within ten (10) days of the date on which such a request is
received, the record date for determining stockholders entitled to consent to
corporate action in writing without a meeting, when no prior action by the Board
of Directors is required by applicable law, shall be the first date on which a
signed written consent setting forth the action taken or proposed to be taken is
delivered to the Corporation by delivery to its registered office in the State
of Delaware, its principal place of business, or any officer or agent of the
Corporation having custody of the book in which proceeding of meetings of
stockholders are recorded. Delivery made to the Corporation's registered office
shall be by hand or by certified or registered mail, return receipt requested.
If no record date has been fixed by the Board of Directors and prior action by
the Board of Directors is required by applicable law, the record date for
determining stockholders entitled to consent to corporate action in writing
without a meeting shall be at the close of business on the date on which the
Board of Directors adopts the resolution taking such prior action.
Section 5. Regulations. The issue, transfer, conversion and
registration of certificates of stock shall be governed by such other
regulations as the Board of Directors may establish.
ARTICLE V - GENERAL PROVISIONS
Section 1. Fiscal Year. Except as from time to time otherwise
designated by the Board of Directors, the fiscal year of the Corporation
shall end on the Saturday closest to December 31.
Section 2. Corporate Seal. The corporate seal shall be in such form
as may be approved by the Board of Directors. The corporate seal may be
altered from time to time by the Board.
Section 3. Waiver of Notice. Whenever any notice whatsoever is required to
be given by the Delaware General Corporation Law, by the Certificate of
Incorporation or by these By-laws, a written waiver of such notice signed by the
person entitled to such notice or such person's duly authorized attorney,
whether before or after the time of the event for which notice is to be given
shall be deemed equivalent to the notice required to be given to such person.
Neither the business nor the purpose of any meeting need be specified in such a
waiver. The appearance of such person at such meeting in person or by proxy,
shall constitute waiver of notice except attendance for the sole purpose of
objecting to the timeliness or lack of notice.
12
<PAGE>
Section 4. Voting of Securities. Subject always to the specific directions
of the Board of Directors, any officer of the Corporation may waive notice of,
and act as, or appoint any person or persons to act as, proxy or
attorney-in-fact for this Corporation (with or without power of substitution)
at, any meeting of stockholders or shareholders of any other corporation or
organization, the securities of which may be held by this Corporation. The Board
of Directors, by resolution from time to time, may confer like powers upon any
other person or persons.
Section 5. Evidence of Authority. A certificate by the Secretary, or an
Assistant Secretary as to any action taken by the stockholders, directors, a
committee or any officer or representative of the Corporation shall as to all
persons who rely on the certificate in good faith be conclusive evidence of such
action.
Section 6. Certificate of Incorporation. All references in these By-laws
to the Certificate of Incorporation shall be deemed to refer to the Third
Amended and Restated Certificate of Incorporation of the Corporation, as
amended, restated and in effect from time to time.
Section 7. Transactions with Interested Parties. No contract or
transaction between the Corporation and one or more of the directors or
officers, or between the Corporation and any other corporation, partnership,
association or other organization in which one or more of the directors or
officers are directors or officers, or have a financial interest, shall be void
or voidable solely for this reason, or solely because the director or officer is
present at or participates in the meeting of the Board of Directors or a
committee of the Board of Directors that authorizes the contract or transaction
or solely because the interested directors' votes are counted for such purpose,
if:
(1) The material facts as to the director's or officer's
relationship or interest and as to the contract or transaction are
disclosed or are known to the Board of Directors or the committee, and the
Board of Directors or committee in good faith authorizes the contract or
transaction by the affirmative votes of a majority of the disinterested
directors, even though the disinterested directors be less than a quorum;
(2) The material facts as to the director's or officer's
relationship or interest and as to the contract or transaction are
disclosed or are known to the stockholders entitled to vote thereon, and
the contract or transaction is specifically approved in good faith by vote
of the stockholders; or
(3) The contract or transaction is fair as to the Corporation as of
the time it is authorized, approved or ratified, by the Board of
Directors, a committee of the Board of Directors, or the stockholders.
Common or interested directors may be counted in determining the presence
of a quorum at a meeting of the Board of Directors or of a committee that
authorizes the contract or transaction.
13
<PAGE>
Section 8. Severability. Any determination that any provision of
these By-laws is for any reason inapplicable, illegal, or ineffective shall
not affect or invalidate any other provision of these By-laws.
ARTICLE VI - AMENDMENTS
Section 1. By the Board of Directors. In furtherance and not in limitation
of the powers conferred by the Delaware General Corporation Law and the
Certificate of Incorporation, the Board of Directors is expressly authorized to
alter, amend or repeal any provision of these By-laws or make new by-laws.
Section 2. By the Stockholders. Except as otherwise provided in Section 3
of this Article VI, the stockholders of the Corporation shall have the power to
alter, amend or repeal any provision of these By-laws or make new by-laws by
affirmative vote of the holders of a majority of the shares of capital stock of
the Corporation issued and outstanding and entitled to vote, voting together as
a single class; provided, however, that the power of the stockholders to, alter,
amend or repeal any provision of these By-laws or make any new by-laws is
further subject to any affirmative vote of the holders of any particular class
or series of capital stock of the Corporation as may be required by the Delaware
General Corporation Law, the Certificate of Incorporation, or these By-laws.
Section 3. Certain Provisions. Notwithstanding any other provision of the
Delaware General Corporation Law, the Certificate of Incorporation, or these
By-laws (including Section 2 of this Article VI), the affirmative vote of the
holders of at least sixty-six and two-thirds percent (66 2/3%) of the shares of
capital stock of the Corporation issued and outstanding and entitled to vote
shall be required to alter, amend or repeal, or make any new by-laws
inconsistent with, Article II or this Article VI of these By-laws. This Section
3 is not intended to abrogate or otherwise affect the power of the Board of
Directors to amend Article II or Article VI pursuant to Section 1 of this
Article VI.
14
THERMO ELECTRON CORPORATION
DEFERRED COMPENSATION PLAN FOR DIRECTORS
As amended and restated as of May 21, 1999
Section 1. Participation. Any director of Thermo Electron Corporation (the
"Company") may elect to have such percentage as he or she may specify of the
fees otherwise payable to him or her deferred and paid to him or her as provided
in this Plan. A director who is also an employee of the Company or any
subsidiary or parent of the Company, shall not be eligible to participate in
this Plan. Each election shall be made by notice in writing delivered to the
Secretary of the Company, in such form as the Secretary shall designate, and
each election shall be applicable only with respect to fees earned subsequent to
the date of the election for the period designated in the form. The term
"participant" as used herein refers to any director who shall have made an
election. No participant may defer the receipt of any fees to be earned after
the later to occur of either (a) the date on which the participant shall retire
from or otherwise cease to engage in his or her principal occupation or
employment or (b) the date on which he or she shall cease to be a director of
the Company, or such earlier date as the Board of Directors of the Company, with
the participant's consent, may designate (the "deferral termination date"). In
the event that the participant's deferral termination date is the date on which
he or she ceases to engage in his or her principal occupation or employment, the
participant or a personal representative shall advise the Company of that date
by written notice delivered to the Secretary of the Company.
Section 2. Establishment of Deferred Compensation Accounts. There shall be
established for each participant an account to be designated as that
participant's deferred compensation account.
Section 3. Allocations to Deferred Compensation Accounts. There shall be
allocated to each participant's deferred compensation account, as of the end of
each quarter, an amount equal to his or her fees for that quarter which that
participant shall have elected to have deferred pursuant to Section 1.
Section 4. Stock Units and Stock Unit Accounts. All amounts allocated to a
participant's deferred compensation account pursuant to Section 3 and Section 5
shall be converted, at the end of each quarter, into stock units by dividing the
accumulated balance in the deferred compensation account as of the end of that
quarter by the average last sale price per share of the Company's common stock
as reported in The Wall Street Journal, for the five business days up to and
including the last business day of that quarter. The number of stock units, so
determined, rounded to the nearest one-hundredth of a share, shall be credited
to a separate stock unit account to be established for the participant, and the
aggregate value thereof as of the last business day of that quarter shall be
charged to the participant's deferred compensation account. No amounts credited
to the participant's deferred compensation account pursuant to Section 5
subsequent to the close of the fiscal year in which occurs the participant's
deferral termination date shall be converted into stock units. Any such amount
shall be distributed in cash as provided in Section 8. A maximum number of
321,757 shares of the Company's common stock may be represented by stock units
credited under this Plan, subject to proportionate adjustment in the event of
any stock dividend, stock split or other capital change affecting the Company's
common stock.
Section 5. Cash Dividend Credits. Additional credits shall be made to a
participant's deferred compensation account, until all distributions shall have
been made from the participant's stock unit account, in amounts equal to the
cash dividends (or the fair market value of dividends paid in property other
than dividends payable in common stock of the Company) which the participant
would have received from time to time had he or she been the owner on the record
dates for the payment of such dividends of the number of shares of the Company's
common stock equal to the number of units in his or her stock unit account on
those dates.
Section 6. Stock Dividend Credits. Additional credits shall be made to a
participant's stock unit account, until all distributions shall have been made
from the participant's stock unit account, of a number of units equal to the
number of shares of the Company's common stock, rounded to the nearest
one-hundredth share, which the participant would have received from time to time
as stock dividends had he or she been the owner on the record dates for the
payments of such stock dividends of the number of units of the Company's common
stock equal to the number of units credited to his or her stock unit account on
those dates.
Section 7. Adjustments in the Event of Certain Transactions. In the event of a
stock dividend, stock split or combination of shares, or other distribution with
respect to holders of Common Stock other than normal cash dividends, the number
of units then credited to a partipant's stock unit account shall be
appropriately adjusted on the same basis. In the event of any recapitalization,
merger or consolidation involving the Company, any transaction in which the
Company becomes a subsidiary of another entity, any sale or other disposition of
all or a substantial portion of the assets of the Company or any similar
transaction, as determined by the Board, the Board in its discretion may
terminate the Plan pursuant to Section 11.
Section 8. Distribution of Stock and Cash After Participant's Deferral
Termination Date. When a participant's deferral termination date shall occur,
the Company shall become obligated to make the distributions prescribed in the
following paragraphs (a) and (b).
(a) The Company shall distribute to the participant the number of shares
of the common stock of the Company which shall equal the total number of units
accumulated in his or her stock unit account as of the close of the fiscal year
in which the participant's deferral termination date occurs. Such distribution
of stock shall be made in ten annual installments, unless, at least six months
prior to his or her deferral termination date, the participant shall have
elected, by notice in writing filed with the Secretary of the Company, to have
such distribution made in five annual installments. In either such case, the
installments shall be of as nearly equal number of shares as practicable,
adjusted to reflect any changes pursuant to Sections 6 and 7 in the number of
units remaining in the participant's stock unit account. The first such
installment shall be distributed within 60 days after the close of the fiscal
year in which the participant's deferral termination date occurs. The remaining
installments shall be distributed at annual intervals thereafter. Anything
herein to the contrary notwithstanding, the Company shall have the option, if
its Board of Directors shall by resolution so determine, in lieu of making
distribution in ten or five annual installments as set forth above, with the
participant's consent, to distribute stock or any remaining installments thereof
in a single distribution at any time following the close of the fiscal year in
which the participant's deferral termination date occurs. Distribution of stock
made hereunder may be made from shares of common stock held in the treasury
and/or from shares of authorized but previously unissued shares of common stock.
(b) The Company shall distribute to the participant sums in cash equal
to the balance credited to his or her deferred compensation account as of the
close of the fiscal year in which his or her deferral termination date occurs
plus such additional amounts as shall be credited thereto from time to time
thereafter pursuant to Section 5. The cash distribution shall be made on the
same dates as the annual distributions made pursuant to paragraph (a) above, and
each cash distribution shall consist of the entire balance credited to the
participant's deferred compensation account at the time of the annual
distribution.
If a participant's deferral termination date shall occur by reason of
his or her death or if he or she shall die after his or her deferral termination
date but prior to receipt of all distributions of stock and cash provided for in
this Section 8, all stock and cash remaining distributable hereunder shall be
distributed to such beneficiary as the participant shall have designated in
writing and filed with the Secretary of the Company or, in the absence of
designation, to the participant's personal representative. Such distributions
shall be made in the same manner and at the same intervals as they would have
been made to the participant had he or she continued to live.
Section 9. Participant's Rights Unsecured. The right of any participant to
receive distributions under Section 8 shall be an unsecured claim against the
general assets of the Company. The Company may but shall not be obligated to
acquire shares of its outstanding common stock from time to time in anticipation
of its obligation to make such distributions, but no participant shall have any
rights in or against any shares of stock so acquired by the Company. All such
stock shall constitute general assets of the Company and may be disposed of by
the Company at such time and for such purposes as it may deem appropriate.
10. Change in Control
10.1 Impact of Event
In the event of a "Change in Control" as defined in Section 10.2, the Plan shall
terminate and full distribution shall be made from all participants' deferred
compensation accounts and stock unit accounts effective upon the Change of
Control.
10.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
Section 11. Amendment and Termination of the Plan. The Board of Directors of the
Company may amend or terminate the Plan at any time and from time to time,
provided, however, that no amendment adversely affecting credits already made to
any participant's deferred compensation account or stock unit account may be
made without the consent of that participant or, if that participant has died,
that participant's beneficiary. Upon termination of the Plan, the Company shall
be obligated to distribute to the participant either of the following as the
Board of Directors of the Company, in its sole discretion, may determine: (i)
the number of shares of the common stock of the Company which shall equal the
total number of units accumulated in the participant's stock unit account as of
the effective date of termination of the Plan or (ii) a sum in cash equal to the
balance credited to the participant's deferred compensation account as of the
effective date of termination of the Plan.
THERMO ELECTRON CORPORATION
DIRECTORS STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
The purpose of this Directors Stock Option Plan (the "Plan") of Thermo
Electron Corporation (the "Company") is to encourage ownership in the Company by
outside directors of the Company whose services are considered essential to the
Company's growth and progress and to provide them with a further incentive to
become directors and to continue as directors of the Company. The Plan is
intended to be a nonstatutory stock option plan.
2. Administration
The Board of Directors, or a Committee (the "Committee") consisting of
one or more directors of the Company appointed by the Board of Directors, shall
supervise and administer the Plan. Grants of stock options under the Plan and
the amount and nature of the options to be granted shall be automatic in
accordance with Section 5. However, all questions of interpretation of the Plan
or of any stock options granted under it shall be determined by the Board of
Directors or the Committee and such determination shall be final and binding
upon all persons having an interest in the Plan.
3. Participation in the Plan
Directors of the Company who are not employees of the Company or any
subsidiary or parent of the Company shall be eligible to participate in the
Plan. Directors who receive grants of stock options in accordance with this Plan
are sometimes referred to herein as "Optionees."
4. Stock Subject to the Plan
The maximum number of shares that may be issued under the Plan shall be
675,000 shares of the Company's Common Stock (the "Common Stock"), subject to
adjustment as provided in Section 9. Shares to be issued upon the exercise of
options granted under the Plan may be either authorized but unissued shares or
shares held by the Company in its treasury. If any option expires or terminates
for any reason without having been exercised in full, the unpurchased shares
subject thereto shall again be available for options thereafter to be granted.
5. Terms and Conditions
A. Annual Stock Option Grants
Each Director of the Company who meets the requirements of Section 3 and
who is holding office immediately following the Annual Meeting of Stockholders
commencing with the Annual Meeting of Stockholders held in calendar year 1993,
shall be granted an option to purchase 1,000 shares of Common Stock at the close
of business on the date of such Annual Meeting.
B. General Terms and Conditions Applicable to All Grants.
1. Options shall be immediately exercisable at any time from and
after the grant date and prior to the date which is the earliest
of:
(a) three years after the grant date for options granted
under Section 5(A), (b) two years after the Optionee ceases to
serve as a director of the Company, Thermo Electron or any
subsidiary of Thermo Electron (one year in the event the Optionee
ceases to meet the requirements of this Subsection by reason of
his or her death), or (c) the date of dissolution or liquidation
of the Company.
2. The exercise price at which Options are granted hereunder
shall be the average of the closing prices reported by the
national securities exchange on which the Common Stock is
principally traded for the five trading days immediately
preceding and including the date the option is granted or, if
such security is not traded on an exchange, the average last
reported sale price for the five-day period on the NASDAQ
National Market List, or the average of the closing bid prices
for the five-day period last quoted by an established quotation
service for over-the-counter securities, or if none of the above
shall apply, the last price paid for shares of the Common Stock
by independent investors in a private placement.
3. All options shall be evidenced by a written agreement
substantially in such form as shall be approved by the Board of
Directors or Committee, containing terms and conditions
consistent with the provisions of this Plan.
6. Exercise of Options
A. Exercise/Consideration
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Common Stock of the
Company (the shares so tendered referred to herein as "Tendered Shares") with a
then current market value equal to the exercise price of the shares to be
purchased; provided, however, that such Tendered Shares shall have been acquired
by the Optionee more than six months prior to the date of exercise (unless such
requirement is waived in writing by the Company). Against such payment the
Company shall deliver or cause to be delivered to the Optionee a certificate for
the number of shares then being purchased, registered in the name of the
Optionee or other person exercising the option. If any law or applicable
regulation of the Securities and Exchange Commission or other body having
jurisdiction in the premises shall require the Company or the Director to take
any action in connection with shares being purchased upon exercise of the
option, exercise of the option and delivery of the certificate or certificates
for such shares shall be postponed until completion of the necessary action,
which shall be taken at the Company's expense.
B. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to the Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan. Subject to the prior approval of the Company, which
may be withheld by the Company in its sole discretion, the Optionee may elect to
satisfy such obligations, in whole or in part, (i) by causing the Company to
withhold shares of Common Stock otherwise issuable pursuant to the exercise of
an option or (ii) by delivering to the Company shares of Common Stock already
owned by the Optionee. The shares so delivered or withheld shall have a fair
market value equal to such withholding obligation. The fair market value of the
shares used to satisfy such withholding obligation shall be determined by the
Company as of the date that the amount of tax to be withheld is to be
determined. Notwithstanding the foregoing, no election to use shares for the
payment of withholding taxes shall be effective unless made in compliance with
any applicable requirements of Rule 16b-3.
7. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during an Optionee's lifetime an Option may be exercised only
by him or her (or in the event of incapacity, the person or persons properly
appointed to act on his or her behalf). The Board may, in its discretion,
determine the extent to which Options granted to an Optionee shall be
transferable, and such provisions permitting or acknowledging transfer shall be
set forth in the written agreement evidencing the Option executed and delivered
by or on behalf of the Company and the Optionee.
8. Limitation of Rights to Continue as a Director
Neither the Plan, nor the quantity of shares subject to options granted
under the Plan, nor any other action taken pursuant to the Plan, shall
constitute or be evidence of any agreement or understanding, express or implied,
that the Company will retain a Director for any period of time, or at any
particular rate of compensation.
9. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 4
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Options
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company or any similar transaction, as determined by the
Board, the Board in its discretion may make appropriate adjustments to
outstanding Options to avoid distortion in the operation of the Plan.
10. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan or the written
agreement evidencing options granted hereunder.
11. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to permit the exercise in full of all options granted under this Plan
and shall pay all other fees and expenses necessarily incurred by the Company in
connection therewith.
12. Securities Laws Restrictions
A. Investment Representations.
The Company may require any person to whom an option is granted, as a
condition of exercising such option, to give written assurances in substance and
form satisfactory to the Company to the effect that such person is acquiring the
Common Stock subject to the option for his or her own account for investment and
not with any present intention of selling or otherwise distributing the same,
and to such other effects as the Company deems necessary or appropriate in order
to comply with federal and applicable state securities laws.
B. Compliance with Securities Laws.
Each option shall be subject to the requirement that if, at any time,
counsel to the Company shall determine that the listing, registration or
qualification of the shares subject to such option upon any securities exchange
or under any state or federal law, or the consent or approval of any
governmental or regulatory body, or that the disclosure of non-public
information or the satisfaction of any other condition is necessary as a
condition of, or in connection with, the issuance or purchase of shares
thereunder, such option may not be exercised, in whole or in part, unless such
listing, registration, qualification, consent or approval, or satisfaction of
such condition shall have been effected or obtained on conditions acceptable to
the Board of Directors. Nothing herein shall be deemed to require the Company to
apply for or to obtain such listing, registration or qualification, or to
satisfy such condition.
13. Change in Control
A. Impact of Event
In the event of a "Change in Control" as defined in Section 13(A), the
following provisions shall apply, unless the agreement evidencing the Award
otherwise provides (by specific explicit reference to Section 13(B) below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, each outstanding Option under the Plan that was not
previously exercisable and vested shall become immediately exercisable in full
and will no longer be subject to a right of repurchase by the Company.
B. Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
14. Amendment of the Plan
The provisions of Sections 3 and 5 of the Plan shall not be amended more
than once every six months, other than to comport with changes in the Code, the
Employee Retirement Income Security Act of 1974, or the rules thereunder.
Subject to the foregoing, the Board of Directors may at any time, and from time
to time, modify or amend the Plan in any respect, except that if at any time the
approval of the Stockholders of the Company is required as to such modification
or amendment under Rule 16b-3, the Board of Directors may not effect such
modification or amendment without such approval.
The termination or any modification or amendment of the Plan shall not,
without the consent of an Optionee, affect his or her rights under an option
previously granted to him or her. With the consent of the Optionees affected,
the Board of Directors may amend outstanding option agreements in a manner not
inconsistent with the Plan. The Board of Directors shall have the right to amend
or modify the terms and provisions of the Plan and of any outstanding option to
the extent necessary to ensure the qualification of the Plan under Rule 16b-3.
15. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors,
but no option granted under the Plan shall become exercisable until six months
after the Plan is approved by the Stockholders of the Company.
16. Notice
Any written notice to the Company required by any of the provisions of
the Plan shall be addressed to the Secretary of the Company and shall become
effective when it is received.
17. Governing Law
The Plan and all determinations made and actions taken pursuant hereto
shall be governed by the laws of the State of Delaware.
THERMO ELECTRON CORPORATION
NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Electron
Corporation ("Company"), by persons selected by the Board of Directors (or a
committee thereof) in its sole discretion, including directors, executive
officers, key employees and consultants of the Company and its subsidiaries, and
to provide additional incentive for them to promote the success of the business
of the Company. The Plan is intended to be a nonstatutory stock option plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan and
the Company's Incentive Stock Option Plan in the aggregate shall be 13,552,731
shares. Shares to be issued upon the exercise of options granted under the Plan
may be either authorized but unissued shares or shares held by the Company in
its treasury. If any option expires or terminates for any reason without having
been exercised in full, the unpurchased shares subject thereto shall again be
available for options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; (f) the
terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Common Stock (the
"Tendered Shares") with a then current market value equal to the option price of
the shares to be purchased; provided, however, that such Tendered Shares shall
have been acquired by the Optionee more than six months prior to the date of
exercise, unless such requirement is waived in writing by the Company. Against
such payment the Company shall deliver or cause to be delivered to the Optionee
a certificate for the number of shares then being purchased, registered in the
name of the Optionee or other person exercising the option. If any law or
applicable regulation of the Securities and Exchange Commission or other body
having jurisdiction in the premises shall require the Company or the Optionee to
take any action in connection with shares being purchased upon exercise of the
option, exercise of the option and delivery of the certificate or certificates
for such shares shall be postponed until completion of the necessary action,
which shall be taken at the Company's expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company or any similar transaction, as determined by the
Board, the Board in its discretion may make appropriate adjustments to
outstanding Options to avoid distortion in the operation of the Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optionee and the Company or unless otherwise agreed by the
Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
EQUITY INCENTIVE PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
The purpose of this Equity Incentive Plan (the "Plan") is to secure for
Thermo Electron Corporation (the "Company") and its Stockholders the benefits
arising from capital stock ownership by employees and Directors of, and
consultants to, the Company and its subsidiaries or other persons who are
expected to make significant contributions to the future growth and success of
the Company and its subsidiaries. The Plan is intended to accomplish these goals
by enabling the Company to offer such persons equity-based interests,
equity-based incentives or performance-based stock incentives in the Company, or
any combination thereof ("Awards").
2. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). The Board shall have full power to interpret and administer the
Plan, to prescribe, amend and rescind rules and regulations relating to the Plan
and Awards, and full authority to select the persons to whom Awards will be
granted ("Participants"), determine the type and amount of Awards to be granted
to Participants (including any combination of Awards), determine the terms and
conditions of Awards granted under the Plan (including terms and conditions
relating to events of merger, consolidation, dissolution and liquidation, change
of control, vesting, forfeiture, restrictions, dividends and interest, if any,
on deferred amounts), waive compliance by a participant with any obligation to
be performed by him or her under an Award, waive any term or condition of an
Award, cancel an existing Award in whole or in part with the consent of a
Participant, grant replacement Awards, accelerate the vesting or lapse of any
restrictions of any Award and adopt the form of instruments evidencing Awards
under the Plan and change such forms from time to time. Any interpretation by
the Board of the terms and provisions of the Plan or any Award thereunder and
the administration thereof, and all action taken by the Board, shall be final,
binding and conclusive on all parties and any person claiming under or through
any party. No Director shall be liable for any action or determination made in
good faith. The Board may, to the full extent permitted by law, delegate any or
all of its responsibilities under the Plan to a committee (the "Committee")
appointed by the Board and consisting of two or more members of the Board, each
of whom shall be deemed a "disinterested person" within the meaning of Rule
16b-3 (or any successor rule) of the Securities Exchange Act of 1934 (the
"Exchange Act").
3. Effective Date
The Plan shall be effective as of the date first approved by the Board
of Directors, subject to the approval of the Plan by the Corporation's
Stockholders. Grants of Awards under the Plan made prior to such approval shall
be effective when made (unless otherwise specified by the Board at the time of
grant), but shall be conditioned on and subject to such approval of the Plan.
4. Shares Subject to the Plan
Subject to adjustment as provided in Section 10.6, the total number of
shares of Common Stock reserved and available for distribution under the Plan
shall be 15,575,000 shares. Such shares may consist, in whole or in part, of
authorized and unissued shares or treasury shares.
If any Award of shares of Common Stock requiring exercise by the
Participant for delivery of such shares terminates without having been exercised
in full, is forfeited or is otherwise terminated without a payment being made to
the Participant in the form of Common Stock, or if any shares of Common Stock
subject to restrictions are repurchased by the Company pursuant to the terms of
any Award or are otherwise reacquired by the Company to satisfy obligations
arising by virtue of any Award, such shares shall be available for distribution
in connection with future Awards under the Plan.
5. Eligibility
Employees and Directors of, and consultants to, the Company and its
subsidiaries, or other persons who are expected to make significant
contributions to the future growth and success of the Company and its
subsidiaries shall be eligible to receive Awards under the Plan. The Board, or
other appropriate committee or person to the extent permitted pursuant to the
last sentence of Section 2, shall from time to time select from among such
eligible persons those who will receive Awards under the Plan.
6. Types of Awards
The Board may offer Awards under the Plan in any form of equity-based
interest, equity-based incentive or performance-based stock incentive in Common
Stock of the Company or any combination thereof. The type, terms and conditions
and restrictions of an Award shall be determined by the Board at the time such
Award is made to a Participant; provided however that the maximum number of
shares permitted to be granted under any Award or combination of Awards to any
Participant during any one calendar year may not exceed 1,500,000 shares of
Common Stock.
An Award shall be made at the time specified by the Board and shall be
subject to such conditions or restrictions as may be imposed by the Board and
shall conform to the general rules applicable under the Plan as well as any
special rules then applicable under federal tax laws or regulations or the
federal securities laws relating to the type of Award granted.
Without limiting the foregoing, Awards may take the following forms and
shall be subject to the following rules and conditions:
6.1 Options
An option is an Award that entitles the holder on exercise thereof to
purchase Common Stock at a specified exercise price. Options granted under the
Plan may be either incentive stock options ("incentive stock options") that meet
the requirements of Section 422 of the Internal Revenue Code of 1986, as amended
(the "Code"), or options that are not intended to meet the requirements of
Section 422 ("non-statutory options").
6.1.1 Option Price. The price at which Common Stock may be purchased
upon exercise of an option shall be determined by the Board, provided however,
the exercise price shall not be less than 85% of the fair market value per share
of Common Stock as of the date of grant. The Board shall not have the authority
to reprice outstanding stock options granted to directors or executive officers
of the Company, except to the extent permitted under Section 10.6 of the Plan in
connection with adjustments in the event of certain transactions.
6.1.2 Option Grants. The granting of an option shall take place at the
time specified by the Board. Options shall be evidenced by option agreements.
Such agreements shall conform to the requirements of the Plan, and may contain
such other provisions (including but not limited to vesting and forfeiture
provisions, acceleration, change of control, protection in the event of merger,
consolidations, dissolutions and liquidations) as the Board shall deem
advisable. Option agreements shall expressly state whether an option grant is
intended to qualify as an incentive stock option or non-statutory option.
6.1.3 Option Period. An option will become exercisable at such time or
times (which may be immediately or in such installments as the Board shall
determine) and on such terms and conditions as the Board shall specify. The
option agreements shall specify the terms and conditions applicable in the event
of an option holder's termination of employment during the option's term.
Any exercise of an option must be in writing, signed by the proper
person and delivered or mailed to the Company, accompanied by (1) any additional
documents required by the Board and (2) payment in full in accordance with
Section 6.1.4 for the number of shares for which the option is exercised.
6.1.4 Payment of Exercise Price. Stock purchased on exercise of an
option shall be paid for as follows: (1) in cash or by check (subject to such
guidelines as the Company may establish for this purpose), bank draft or money
order payable to the order of the Company or (2) if so permitted by the
instrument evidencing the option (or in the case of a non-statutory option, by
the Board at or after grant of the option), (i) through the delivery of shares
of Common Stock that have been outstanding for at least six months (unless the
Board expressly approves a shorter period) and that have a fair market value
(determined in accordance with procedures prescribed by the Board) equal to the
exercise price, (ii) by delivery of a promissory note of the option holder to
the Company, payable on such terms as are specified by the Board, (iii) by
delivery of an unconditional and irrevocable undertaking by a broker to deliver
promptly to the Company sufficient funds to pay the exercise price, or (iv) by
any combination of the permissible forms of payment.
6.1.5 Buyout Provision. The Board may at any time offer to buy out for a
payment in cash, shares of Common Stock, deferred stock or restricted stock, an
option previously granted, based on such terms and conditions as the Board shall
establish and communicate to the option holder at the time that such offer is
made.
6.1.6 Special Rules for Incentive Stock Options. Each provision of the
Plan and each option agreement evidencing an incentive stock option shall be
construed so that each incentive stock option shall be an incentive stock option
as defined in Section 422 of the Code or any statutory provision that may
replace such Section, and any provisions thereof that cannot be so construed
shall be disregarded. Instruments evidencing incentive stock options must
contain such provisions as are required under applicable provisions of the Code.
Incentive stock options may be granted only to employees of the Company and its
subsidiaries. The exercise price of an incentive stock option shall not be less
than 100% (110% in the case of an incentive stock option granted to a more than
ten percent Stockholder of the Company) of the fair market value of the Common
Stock on the date of grant, as determined by the Board. An incentive stock
option may not be granted after the tenth anniversary of the date on which the
Plan was adopted by the Board and the latest date on which an incentive stock
option may be exercised shall be the tenth anniversary (fifth anniversary, in
the case of any incentive stock option granted to a more than ten percent
Stockholder of the Company) of the date of grant, as determined by the Board.
6.2 Restricted and Unrestricted Stock
An Award of restricted stock entitles the recipient thereof to acquire
shares of Common Stock upon payment of the purchase price subject to
restrictions specified in the instrument evidencing the Award.
6.2.1 Restricted Stock Awards. Awards of restricted stock shall be
evidenced by restricted stock agreements. Such agreements shall conform to the
requirements of the Plan, and may contain such other provisions (including
restriction and forfeiture provisions, change of control, protection in the
event of mergers, consolidations, dissolutions and liquidations) as the Board
shall deem advisable.
6.2.2 Restrictions. Until the restrictions specified in a restricted
stock agreement shall lapse, restricted stock may not be sold, assigned,
transferred, pledged or otherwise encumbered or disposed of, and upon certain
conditions specified in the restricted stock agreement, must be resold to the
Company for the price, if any, specified in such agreement. The restrictions
shall lapse at such time or times, and on such conditions, as the Board may
specify. The Board may at any time accelerate the time at which the restrictions
on all or any part of the shares shall lapse.
6.2.3 Rights as a Stockholder. A Participant who acquires shares of
restricted stock will have all of the rights of a Stockholder with respect to
such shares including the right to receive dividends and to vote such shares.
Unless the Board otherwise determines, certificates evidencing shares of
restricted stock will remain in the possession of the Company until such shares
are free of all restrictions under the Plan.
6.2.4 Purchase Price. The purchase price of shares of restricted stock
shall be determined by the Board, in its sole discretion, but such price may not
be less than the par value of such shares.
6.2.5 Other Awards Settled With Restricted Stock. The Board may provide
that any or all the Common Stock delivered pursuant to an Award will be
restricted stock.
6.2.6 Unrestricted Stock. The Board may, in its sole discretion, sell to
any Participant shares of Common Stock free of restrictions under the Plan for a
price determined by the Board, but which may not be less than the par value per
share of the Common Stock.
6.3 Deferred Stock
6.3.1 Deferred Stock Award. A deferred stock Award entitles the
recipient to receive shares of deferred stock, which is Common Stock to be
delivered in the future. Delivery of the Common Stock will take place at such
time or times, and on such conditions, as the Board may specify. The Board may
at any time accelerate the time at which delivery of all or any part of the
Common Stock will take place.
6.3.2 Other Awards Settled with Deferred Stock. The Board may, at the
time any Award described in this Section 6 is granted, provide that, at the time
Common Stock would otherwise be delivered pursuant to the Award, the Participant
will instead receive an instrument evidencing the right to future delivery of
deferred stock.
6.4 Performance Awards
6.4.1 Performance Awards. A performance Award entitles the recipient to
receive, without payment, an amount, in cash or Common Stock or a combination
thereof (such form to be determined by the Board), following the attainment of
performance goals. Performance goals may be related to personal performance,
corporate performance, departmental performance or any other category of
performance deemed by the Board to be important to the success of the Company.
The Board will determine the performance goals, the period or periods during
which performance is to be measured and all other terms and conditions
applicable to the Award.
6.4.2 Other Awards Subject to Performance Conditions. The Board may, at
the time any Award described in this Section 6 is granted, impose the condition
(in addition to any conditions specified or authorized in this Section 6 of the
Plan) that performance goals be met prior to the Participant's realization of
any payment or benefit under the Award.
7. Purchase Price and Payment
Except as otherwise provided in the Plan, the purchase price of Common
Stock to be acquired pursuant to an Award shall be the price determined by the
Board, provided that such price shall not be less than the par value of the
Common Stock. Except as otherwise provided in the Plan, the Board may determine
the method of payment of the exercise price or purchase price of an Award
granted under the Plan and the form of payment. The Board may determine that all
or any part of the purchase price of Common Stock pursuant to an Award has been
satisfied by past services rendered by the Participant. The Board may agree at
any time, upon request of the Participant, to defer the date on which any
payment under an Award will be made.
8. Loans and Supplemental Grants
The Company may make a loan to a Participant, either on or after the
grant to the Participant of any Award, in connection with the purchase of Common
Stock under the Award or with the payment of any obligation incurred or
recognized as a result of the Award. The Board will have full authority to
decide whether the loan is to be secured or unsecured or with or without
recourse against the borrower, the terms on which the loan is to be repaid and
the conditions, if any, under which it may be forgiven.
In connection with any Award, the Board may at the time such Award is
made or at a later date, provide for and make a cash payment to the participant
not to exceed an amount equal to (a) the amount of any federal, state and local
income tax or ordinary income for which the Participant will be liable with
respect to the Award, plus (b) an additional amount on a grossed-up basis
necessary to make him or her whole after tax, discharging all the participant's
income tax liabilities arising from all payments under the Plan.
9. Change in Control
9.1 Impact of Event
In the event of a "Change in Control" as defined in Section 9.2, the
following provisions shall apply, unless the agreement evidencing the Award
otherwise provides (by specific explicit reference to Section 9.2 below). If a
Change in Control occurs while any Awards are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option or other stock-based
Award awarded under the Plan that was not previously exercisable and vested
shall become immediately exercisable in full and will no longer be subject to a
right of repurchase by the Company, (ii) each outstanding restricted stock award
or other stock-based Award subject to restrictions and to the extent not fully
vested, shall be deemed to be fully vested, free of restrictions and no longer
subject to a right of repurchase by the Company, and (iii) deferral limitations
and conditions that relate solely to the passage of time, continued employment
or affiliation will be waived and removed as to deferred stock Awards and
performance Awards; performance of other conditions (other than conditions
relating solely to the passage of time, continued employment or affiliation)
will continue to apply unless otherwise provided in the agreement evidencing the
Award or in any other agreement between the Participant and the Company or
unless otherwise agreed by the Board.
9.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
10. General Provisions
10.1 Documentation of Awards
Awards will be evidenced by written instruments, which may differ among
Participants, prescribed by the Board from time to time. Such instruments may be
in the form of agreements to be executed by both the Participant and the Company
or certificates, letters or similar instruments which need not be executed by
the participant but acceptance of which will evidence agreement to the terms
thereof. Such instruments shall conform to the requirements of the Plan and may
contain such other provisions (including provisions relating to events of
merger, consolidation, dissolution and liquidations, change of control and
restrictions affecting either the agreement or the Common Stock issued
thereunder), as the Board deems advisable.
10.2 Rights as a Stockholder
Except as specifically provided by the Plan or the instrument evidencing
the Award, the receipt of an Award will not give a Participant rights as a
Stockholder with respect to any shares covered by an Award until the date of
issue of a stock certificate to the participant for such shares.
10.3 Conditions on Delivery of Stock
The Company will not be obligated to deliver any shares of Common Stock
pursuant to the Plan or to remove any restriction from shares previously
delivered under the Plan (a) until all conditions of the Award have been
satisfied or removed, (b) until, in the opinion of the Company's counsel, all
applicable federal and state laws and regulations have been complied with, (c)
if the outstanding Common Stock is at the time listed on any stock exchange,
until the shares have been listed or authorized to be listed on such exchange
upon official notice of issuance, and (d) until all other legal matters in
connection with the issuance and delivery of such shares have been approved by
the Company's counsel. If the sale of Common Stock has not been registered under
the Securities Act of 1933, as amended, the Company may require, as a condition
to exercise of the Award, such representations or agreements as counsel for the
Company may consider appropriate to avoid violation of such act and may require
that the certificates evidencing such Common Stock bear an appropriate legend
restricting transfer.
If an Award is exercised by the participant's legal representative, the
Company will be under no obligation to deliver Common Stock pursuant to such
exercise until the Company is satisfied as to the authority of such
representative.
10.4 Tax Withholding
The Company will withhold from any cash payment made pursuant to an
Award an amount sufficient to satisfy all federal, state and local withholding
tax requirements (the "withholding requirements").
In the case of an Award pursuant to which Common Stock may be delivered,
the Board will have the right to require that the participant or other
appropriate person remit to the Company an amount sufficient to satisfy the
withholding requirements, or make other arrangements satisfactory to the Board
with regard to such requirements, prior to the delivery of any Common Stock. If
and to the extent that such withholding is required, the Board may permit the
participant or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirement.
10.5 Transferability of Awards
Except as may be authorized by the Board, in its sole discretion, no
Award (other than an Award in the form of an outright transfer of cash or Common
Stock not subject to any restrictions) may be transferred other than by will or
the laws of descent and distribution, and during a Participant's lifetime an
Award requiring exercise may be exercised only by him or her (or in the event of
incapacity, the person or persons properly appointed to act on his or her
behalf). The Board may, in its discretion, determine the extent to which Awards
granted to a Participant shall be transferable, and such provisions permitting
or acknowledging transfer shall be set forth in the written agreement evidencing
the Award executed and delivered by or on behalf of the Company and the
Participant.
10.6 Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 4
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Awards then outstanding or subsequently granted,
any exercise prices relating to Awards and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company or any similar transaction, as determined by the
Board, the Board in its discretion may make appropriate adjustments to
outstanding Awards to avoid distortion in the operation of the Plan.
10.7 Employment Rights
Neither the adoption of the Plan nor the grant of Awards will confer
upon any person any right to continued employment with the Company or any
subsidiary or interfere in any way with the right of the Company or subsidiary
to terminate any employment relationship at any time or to increase or decrease
the compensation of such person. Except as specifically provided by the Board in
any particular case, the loss of existing or potential profit in Awards granted
under the Plan will not constitute an element of damages in the event of
termination of an employment relationship even if the termination is in
violation of an obligation of the Company to the employee.
Whether an authorized leave of absence, or absence in military or
government service, shall constitute termination of employment shall be
determined by the Board at the time. For purposes of this Plan, transfer of
employment between the Company and its subsidiaries shall not be deemed
termination of employment.
10.8 Other Employee Benefits
The value of an Award granted to a Participant who is an employee, and
the amount of any compensation deemed to be received by an employee as a result
of any exercise or purchase of Common Stock pursuant to an Award or sale of
shares received under the Plan, will not constitute "earnings" or "compensation"
with respect to which any other employee benefits of such employee are
determined, including without limitation benefits under any pension, stock
ownership, stock purchase, life insurance, medical, health, disability or salary
continuation plan.
10.9 Legal Holidays
If any day on or before which action under the Plan must be taken falls
on a Saturday, Sunday or legal holiday, such action may be taken on the next
succeeding day not a Saturday, Sunday or legal holiday.
10.10 Foreign Nationals
Without amending the Plan, Awards may be granted to persons who are
foreign nationals or employed outside the United States or both, on such terms
and conditions different from those specified in the Plan, as may, in the
judgment of the Board, be necessary or desirable to further the purpose of the
Plan.
11. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 11, the Board may at any
time or times amend the Plan or any outstanding Award for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Awards. No amendment of the Plan or any agreement evidencing
Awards under the Plan may adversely affect the rights of any participant under
any Award previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMEDICS INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermedics Inc.
("Subsidiary"), a subsidiary of Thermo Electron Corporation (the "Company"), by
persons selected by the Board of Directors (or a committee thereof) in its sole
discretion, including directors, executive officers, key employees and
consultants of the Company and its subsidiaries, and to provide additional
incentive for them to promote the success of the business of the Company and
Subsidiary.
The Plan is intended to be a nonstatutory stock option plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 450,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO INSTRUMENT SYSTEMS INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Instrument
Systems Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 72,968 shares. Shares to be issued upon the exercise of options granted under
the Plan shall be shares of Subsidiary beneficially owned by the Company. If any
option expires or terminates for any reason without having been exercised in
full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO TERRATECH INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo TerraTech
Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 59,750 shares. Shares to be issued upon the exercise of options granted under
the Plan shall be shares of Subsidiary beneficially owned by the Company. If any
option expires or terminates for any reason without having been exercised in
full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO POWER CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Power
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 488,400 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO CARDIOSYSTEMS INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo
Cardiosystems Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation
(the "Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 250,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO ECOTEK CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Ecotek
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 487,500 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMOTREX CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoTrex
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 225,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO FIBERTEK INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Fibertek
Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 900,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO VOLTEK CORP. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") was originally intended
to encourage ownership of common stock of Thermo Voltek Corp. ("Subsidiary"), a
subsidiary of Thermo Electron Corporation (the "Company"), by persons selected
by the Board of Directors (or a committee thereof) in its sole discretion,
including directors, executive officers, key employees and consultants of the
Company and its subsidiaries, and to provide additional incentive for them to
promote the success of the business of the Company and Subsidiary. The options
outstanding under the Plan on the effective time of the merger of the Subsidiary
with and into a subsidiary of Thermedics Inc., another subsidiary of the
Company, (the "Merger") were exchanged for options to purchase shares of common
stock of Thermedics Inc. (the "Common Stock"). The Plan is intended to be a
nonstatutory stock option plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 33,146 shares as of the effective time of the Merger. Shares to be issued
upon the exercise of options granted under the Plan shall be shares of
Subsidiary beneficially owned by the Company. If any option expires or
terminates for any reason without having been exercised in full, the unpurchased
shares subject thereto shall again be available for options thereafter to be
granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO BIOANALYSIS CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo BioAnalysis
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMOLYTE CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoLyte
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMORETEC CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoRetec
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 100,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMOSPECTRA CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoSpectra
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 100,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMOLASE CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoLase
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 300,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMOQUEST CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ThermoQuest
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 375,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO OPTEK CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Optek
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 375,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO SENTRON INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Sentron Inc.
("Subsidiary"), a subsidiary of Thermo Electron Corporation (the "Company"), by
persons selected by the Board of Directors (or a committee thereof) in its sole
discretion, including directors, executive officers, key employees and
consultants of the Company and its subsidiaries, and to provide additional
incentive for them to promote the success of the business of the Company and
Subsidiary.
The Plan is intended to be a nonstatutory stock option plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
TREX MEDICAL CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Trex Medical
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 350,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO FIBERGEN INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Fibergen
Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMEDICS DETECTION INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermedics
Detection Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
METRIKA SYSTEMS CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Metrika Systems
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO VISION CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Vision
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
ONIX SYSTEMS INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of ONIX Systems Inc.
("Subsidiary"), a subsidiary of Thermo Electron Corporation (the "Company"), by
persons selected by the Board of Directors (or a committee thereof) in its sole
discretion, including directors, executive officers, key employees and
consultants of the Company and its subsidiaries, and to provide additional
incentive for them to promote the success of the business of the Company and
Subsidiary.
The Plan is intended to be a nonstatutory stock option plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THE RANDERS KILLAM GROUP INC. NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of The Randers Killam
Group Inc. ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 300,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
TREX COMMUNICATIONS CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Trex Communications
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
THERMO ELECTRON CORPORATION
THERMO TRILOGY CORPORATION NONQUALIFIED STOCK OPTION PLAN
As amended and restated effective as of May 21, 1999
1. Purpose
This Nonqualified Stock Option Plan (the "Plan") is intended to
encourage ownership of Common Stock (the "Common Stock"), of Thermo Trilogy
Corporation ("Subsidiary"), a subsidiary of Thermo Electron Corporation (the
"Company"), by persons selected by the Board of Directors (or a committee
thereof) in its sole discretion, including directors, executive officers, key
employees and consultants of the Company and its subsidiaries, and to provide
additional incentive for them to promote the success of the business of the
Company and Subsidiary. The Plan is intended to be a nonstatutory stock option
plan.
2. Effective Date of the Plan
The Plan shall become effective when adopted by the Board of Directors
of the Company.
3. Stock Subject to Plan
Subject to adjustment as provided in Section 11, the total number of
shares of Common Stock reserved and available for issuance under the Plan shall
be 150,000 shares. Shares to be issued upon the exercise of options granted
under the Plan shall be shares of Subsidiary beneficially owned by the Company.
If any option expires or terminates for any reason without having been exercised
in full, the unpurchased shares subject thereto shall again be available for
options thereafter to be granted.
4. Administration
The Plan will be administered by the Board of Directors of the Company
(the "Board"). Subject to the provisions of the Plan, the Board shall have
complete authority, in its discretion, to make the following determinations with
respect to each option to be granted by the Company: (a) the person to receive
the option (the "Optionee"); (b) the time of granting the option; (c) the number
of shares subject thereto; (d) the option price; (e) the option period; and (f)
the terms and conditions of options granted under the Plan (including terms and
conditions relating to events of merger, consolidation, dissolution and
liquidation, change of control, vesting, forfeiture, restrictions, dividends and
interest, if any, on deferred amounts); (g) waive compliance by an optionee with
any obligation to be performed by him or her under an option; (h) waive any term
or condition of an option; (i) cancel an existing option in whole or in part
with the consent of an Optionee; (j) grant replacement options; (k) accelerate
the vesting or lapse of any restrictions of any option; and (l) adopt the form
of instruments evidencing options under the Plan and change such forms from time
to time. In making such determinations, the Board may take into account the
nature of the services rendered by the Optionees, their present and potential
contributions to the success of the Company and/or one or more of its
subsidiaries, and such other factors as the Board in its discretion shall deem
relevant. Subject to the provisions of the Plan, the Board shall also have
complete authority to interpret the Plan, to prescribe, amend, and rescind rules
and regulations relating to it, to determine the terms and provisions of the
respective option agreements (which need not be identical), and to make all
other determinations necessary or advisable for the administration of the Plan.
Any interpretation by the Board of the terms and provisions of the Plan or any
Award thereunder and the administration thereof, and all action taken by the
Board, shall be final, binding and conclusive on all parties and any person
claiming under or through any party. No Director shall be liable for any action
or determination made in good faith. The Board may, to the full extent permitted
by law, delegate any or all of its responsibilities under the Plan to a
committee (the "Committee") appointed by the Board and consisting of two or more
members of the Board, each of whom shall be deemed a "disinterested person"
within the meaning of Rule 16b-3 (or any successor rule) of the Securities
Exchange Act of 1934 (the "Exchange Act").
5. Eligibility
An option may be granted to any person selected by the Board in its sole
discretion.
6. Time of Granting Options
The granting of an option shall take place at the time specified by the
Board. Only if expressly so provided by the Board shall the granting of an
option be regarded as taking place at the time when a written option agreement
shall have been duly executed and delivered by or on behalf of the Company and
the Optionee to whom such option shall be granted. The agreement shall provide,
among other things, that it does not confer upon an Optionee any right to
continue in the employ of the Company and/or one or more of its subsidiaries or
to continue as a director or consultant of the Company, and that it does not
interfere in any way with the right of the Company or any such subsidiary to
terminate the employment of the Optionee at any time if the Optionee is an
employee, to remove the Optionee as a director of the Company if the Optionee is
a director, or to terminate the services of the Optionee if the Optionee is a
consultant.
7. Option Period
An option may become exercisable immediately or in such installments,
cumulative or noncumulative, as the Board may determine.
8. Exercise of Option
An option may be exercised in accordance with its terms by written
notice of intent to exercise the option, specifying the number of shares of
stock with respect to which the option is then being exercised. The notice shall
be accompanied by payment in the form of cash or shares of Subsidiary Common
Stock (the "Tendered Shares") with a then current market value equal to the
option price of the shares to be purchased; provided, however, that such
Tendered Shares shall have been acquired by the Optionee more than six months
prior to the date of exercise, unless such requirement is waived in writing by
the Company. Against such payment the Company shall deliver or cause to be
delivered to the Optionee a certificate for the number of shares then being
purchased, registered in the name of the Optionee or other person exercising the
option. If any law or applicable regulation of the Securities and Exchange
Commission or other body having jurisdiction in the premises shall require the
Company, Subsidiary or the Optionee to take any action in connection with shares
being purchased upon exercise of the option, exercise of the option and delivery
of the certificate or certificates for such shares shall be postponed until
completion of the necessary action, which shall be taken at the Company's
expense.
9. Transferability
Except as may be authorized by the Board, in its sole discretion, no
Option may be transferred other than by will or the laws of descent and
distribution, and during a Optionee's lifetime an option requiring exercise may
be exercised only by him or her (or in the event of incapacity, the person or
persons properly appointed to act on his or her behalf). The Board may, in its
discretion, determine the extent to which options granted to an Optionee shall
be transferable, and such provisions permitting or acknowledging transfer shall
be set forth in the written agreement evidencing the option executed and
delivered by or on behalf of the Company and the Optionee.
10. Vesting, Restrictions and Termination of Options
The Board, in its sole discretion, may determine the manner in which
options shall vest, the rights of the Company to repurchase the shares issued
upon the exercise of any option and the manner in which such rights shall lapse,
and the terms upon which any option granted shall terminate. The Board shall
have the right to accelerate the date of exercise of any installment or to
accelerate the lapse of the Company's repurchase rights. All of such terms shall
be specified in a written option agreement executed and delivered by or on
behalf of the Company and the Optionee to whom such option shall be granted.
11. Adjustments in the Event of Certain Transactions
(a) In the event of a stock dividend, stock split or combination of
shares, or other distribution with respect to holders of Common Stock other than
normal cash dividends, the Board will make (i) appropriate adjustments to the
maximum number of shares that may be delivered under the Plan under Section 3
above, and (ii) appropriate adjustments to the number and kind of shares of
stock or securities subject to Options then outstanding or subsequently granted,
any exercise prices relating to Options and any other provisions of Awards
affected by such change.
(b) In the event of any recapitalization, merger or consolidation
involving the Company, any transaction in which the Company becomes a subsidiary
of another entity, any sale or other disposition of all or a substantial portion
of the assets of the Company, any transaction which results in Thermo Electron
Corporation ceasing to be the beneficial owner of a majority of the
then-outstanding shares of Common Stock, or any similar transaction, as
determined by the Board, the Board in its discretion may make appropriate
adjustments to outstanding Options to avoid distortion in the operation of the
Plan.
12. Change in Control
12.1 Impact of Event
In the event of a "Change in Control" as defined in Section 12.2, the
following provisions shall apply, unless the agreement evidencing the Option
otherwise provides (by specific explicit reference to Section 12.2 below). If a
Change in Control occurs while any Options are outstanding, then, effective upon
the Change in Control, (i) each outstanding stock option granted under the Plan
that was not previously exercisable and vested shall become immediately
exercisable in full and will no longer be subject to a right of repurchase by
the Company, (ii) each outstanding Option subject to restrictions and to the
extent not fully vested, shall be deemed to be fully vested, free of
restrictions and no longer subject to a right of repurchase by the Company, and
(iii) performance of other conditions (other than conditions relating solely to
the passage of time, continued employment or affiliation) will continue to apply
unless otherwise provided in the agreement evidencing the Option or in any other
agreement between the Optioneet and the Company or unless otherwise agreed by
the Board.
12.2 Definition of "Change in Control"
"Change in Control" means an event or occurrence set forth in any one or
more of subsections (a) through (d) below (including an event or occurrence that
constitutes a Change in Control under one of such subsections but is
specifically exempted from another such subsection):
(a) the acquisition by an individual, entity or group (within the
meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership of any capital stock of Thermo Electron Corporation
("Thermo Electron") if, after such acquisition, such Person beneficially owns
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) 40% or
more of either (i) the then-outstanding shares of common stock of Thermo
Electron (the "Outstanding TMO Common Stock") or (ii) the combined voting power
of the then-outstanding securities of Thermo Electron entitled to vote generally
in the election of directors (the "Outstanding TMO Voting Securities");
provided, however, that for purposes of this subsection (a), the following
acquisitions shall not constitute a Change in Control: (i) any acquisition by
Thermo Electron, (ii) any acquisition by any employee benefit plan (or related
trust) sponsored or maintained by Thermo Electron or any corporation controlled
by Thermo Electron, or (iii) any acquisition by any corporation pursuant to a
transaction which complies with clauses (i) and (ii) of subsection (c) of this
definition; or
(b) such time as the Continuing Directors (as defined below) do not
constitute a majority of the Board of Directors of Thermo Electron (the "Thermo
Board") (or, if applicable, the Board of Directors of a successor corporation to
Thermo Electron), where the term "Continuing Director" means at any date a
member of the Thermo Board (i) who was a member of the Thermo Board as of July
1, 1999 or (ii) who was nominated or elected subsequent to such date by at least
a majority of the directors who were Continuing Directors at the time of such
nomination or election or whose election to the Thermo Board was recommended or
endorsed by at least a majority of the directors who were Continuing Directors
at the time of such nomination or election; provided, however, that there shall
be excluded from this clause (ii) any individual whose initial assumption of
office occurred as a result of an actual or threatened election contest with
respect to the election or removal of directors or other actual or threatened
solicitation of proxies or consents, by or on behalf of a person other than the
Thermo Board; or
(c) the consummation of a merger, consolidation, reorganization,
recapitalization or statutory share exchange involving Thermo Electron or a sale
or other disposition of all or substantially all of the assets of Thermo
Electron in one or a series of transactions (a "Business Combination"), unless,
immediately following such Business Combination, each of the following two
conditions is satisfied: (i) all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding TMO Common Stock and
Outstanding TMO Voting Securities immediately prior to such Business Combination
beneficially own, directly or indirectly, more than 60% of the then-outstanding
shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business
Combination (which shall include, without limitation, a corporation which as a
result of such transaction owns Thermo Electron or substantially all of Thermo
Electron's assets either directly or through one or more subsidiaries) (such
resulting or acquiring corporation is referred to herein as the "Acquiring
Corporation") in substantially the same proportions as their ownership,
immediately prior to such Business Combination, of the Outstanding TMO Common
Stock and Outstanding TMO Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related
trust) maintained or sponsored by Thermo Electron or by the Acquiring
Corporation) beneficially owns, directly or indirectly, 40% or more of the then
outstanding shares of common stock of the Acquiring Corporation, or of the
combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or
(d) approval by the stockholders of Thermo Electron of a complete
liquidation or dissolution of Thermo Electron.
13. Limitation of Rights in Option Stock
The Optionees shall have no rights as stockholders in respect of shares
as to which their options shall not have been exercised, certificates issued and
delivered and payment as herein provided made in full, and shall have no rights
with respect to such shares not expressly conferred by this Plan.
14. Stock Reserved
The Company shall at all times during the term of the options reserve
and keep available such number of shares of the Common Stock as will be
sufficient to satisfy the requirements of this Plan and shall pay all other fees
and expenses necessarily incurred by the Company in connection therewith.
15. Securities Laws Restrictions
Each Optionee exercising an option, at the request of the Company, will
be required to give a representation in form satisfactory to counsel for the
Company that he will not transfer, sell or otherwise dispose of the shares
received upon exercise of the option at any time purchased by him, upon exercise
of any portion of the option, in a manner which would violate the Securities Act
of 1933, as amended, and the regulations of the Securities and Exchange
Commission thereunder and the Company may, if required or at its discretion,
make a notation on any certificates issued upon exercise of options to the
effect that such certificate may not be transferred except after receipt by the
Company of an opinion of counsel satisfactory to it to the effect that such
transfer will not violate such Act and such regulations.
16. Tax Withholding
The Company shall have the right to deduct from payments of any kind
otherwise due to an Optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan (the "withholding requirements"). The Board will have
the right to require that the Optionee or other appropriate person remit to the
Company an amount sufficient to satisfy the withholding requirements, or make
other arrangements satisfactory to the Board with regard to such requirements,
prior to the delivery of any Common Stock pursuant to exercise of an option. If
and to the extent that such withholding is required, the Board may permit the
Optionee or such other person to elect at such time and in such manner as the
Board provides to have the Company hold back from the shares to be delivered, or
to deliver to the Company, Common Stock having a value calculated to satisfy the
withholding requirements.
17. Termination and Amendment
The Plan shall remain in full force and effect until terminated by the
Board. Subject to the last sentence of this Section 17, the Board may at any
time or times amend the Plan or any outstanding Option for any purpose that may
at the time be permitted by law, or may at any time terminate the Plan as to any
further grants of Options. No amendment of the Plan or any agreement evidencing
Options under the Plan may adversely affect the rights of any participant under
any Option previously granted without such participant's consent.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMO
ELECTRON CORPORATION'S QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED JULY
3, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> JAN-01-2000
<PERIOD-END> JUL-03-1999
<CASH> 386,864
<SECURITIES> 681,197
<RECEIVABLES> 993,500
<ALLOWANCES> 63,272
<INVENTORY> 645,992
<CURRENT-ASSETS> 2,941,764
<PP&E> 1,153,583
<DEPRECIATION> 442,735
<TOTAL-ASSETS> 5,934,991
<CURRENT-LIABILITIES> 1,239,543
<BONDS> 1,983,760
0
0
<COMMON> 167,253
<OTHER-SE> 1,785,882
<TOTAL-LIABILITY-AND-EQUITY> 5,934,991
<SALES> 2,006,466
<TOTAL-REVENUES> 2,101,878
<CGS> 1,224,548
<TOTAL-COSTS> 1,308,924 <F1>
<OTHER-EXPENSES> 517,188 <F2>
<LOSS-PROVISION> 9,348
<INTEREST-EXPENSE> 55,474
<INCOME-PRETAX> (307,020)
<INCOME-TAX> (56,733)
<INCOME-CONTINUING> (206,889)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (206,889)
<EPS-BASIC> (1.31)
<EPS-DILUTED> (1.32)
<FN>
<F1> THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT
ACCOUNTS: "COST OF PRODUCT AND SERVICE REVENUES" AND
"COST OF RESEARCH AND DEVELOPMENT CONTRACTS".
<F2> THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT
ACCOUNTS: "RESTRUCTURING AND OTHER NONRECURRING INCOME, NET" AND
"INTERNALLY FUNDED RESEARCH AND DEVELOPMENT".
</FN>
</TABLE>
